<doc>
  <docmeta id="113s957is">
    <bill congress="113" type="s" number="957" version="is"/>
    <revision size="155887" annotations="0" status="complete" id="12" commit-time="2013-10-03T18:34:09Z" committer="mbohmer" doc="113s957is/12.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 S957 IS: Drug Supply Chain Security Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2013-05-15</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 957</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20130515">May 15, 2013</action-date>
			<action-desc>
        <sponsor name-id="S330">Mr. Bennet</sponsor> (for himself,
			 <cosponsor name-id="S300">Mr. Burr</cosponsor>, <cosponsor name-id="S172">Mr.
			 Harkin</cosponsor>, <cosponsor name-id="S289">Mr. Alexander</cosponsor>, and
			 <cosponsor name-id="S305">Mr. Isakson</cosponsor>) introduced the following
			 bill; which was read twice and referred to the
			 <committee-name committee-id="SSHR00">Committee on Health, Education, Labor,
			 and Pensions</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Federal Food, Drug, and Cosmetic Act with
		  respect to the pharmaceutical distribution supply chain.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one">
      <enum>1.</enum>
      <header>Short
			 title</header>
      <text display-inline="no-display-inline">This Act may be cited as
			 the <quote>
          <short-title>Drug Supply Chain Security
			 Act</short-title>
        </quote>.</text>
		</section>
    <section id="id152ccba45d2d4c529aa71d3141e42f5d">
      <enum>2.</enum>
      <header>Pharmaceutical
			 distribution supply chain</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/ch:V">Chapter V of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/351">
            <cato:entity-ref entity-type="uscode" value="usc/21/351/etseq">21 U.S.C. 351 et seq.</cato:entity-ref>
          </external-xref>)</cato:entity> is amended by adding at the end the
			 following:</text>
			<quoted-block display-inline="no-display-inline" id="id5bdb07e4de4041be82c5abe03118f8b3" style="OLC">
				<subchapter id="idd8202d6f2a164af786469a74f7d1d26c">
          <enum>H</enum>
          <header>Pharmaceutical
				distribution supply chain</header>
					<section id="id3a18d9b0d1dd4088a70189c2cc31802e">
            <enum>581.</enum>
            <header>Definitions</header>
            <text display-inline="no-display-inline">In this subchapter:</text>
						<paragraph id="ideef85786e6e4448a82a8fdc3a8d0cd4b">
              <enum>(1)</enum>
              <header>Authorized</header>
              <text>The
				term <term>authorized</term> means—</text>
							<subparagraph id="id5fd0b970ed59442ebd08725e85b9f2a6">
                <enum>(A)</enum>
                <text>in the case of a
				manufacturer or repackager, having a valid registration in accordance with
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:510">section 510</cato:entity-ref>;</text>
							</subparagraph>
              <subparagraph id="idc777bdcd84684193a11ff361923eb832">
                <enum>(B)</enum>
                <text>in the case of a
				wholesale distributor, having a valid license under State law or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:583" proposed="true">section 583</cato:entity-ref>,
				in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:6" proposed="true">section 582(a)(6)</cato:entity-ref> and complying with the licensure reporting
				requirements under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e" proposed="true">section 503(e)</cato:entity-ref>, as amended by the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>;</text>
							</subparagraph>
              <subparagraph id="idb5edff8174814ba48dbf752f38eadfe8">
                <enum>(C)</enum>
                <text>in the case of a
				third-party logistics provider, having a valid license under State law or
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584/ss:a/p:1" proposed="true">section 584(a)(1)</cato:entity-ref>, in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:7" proposed="true">section 582(a)(7)</cato:entity-ref> and complying with the
				licensure reporting requirements under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584/ss:b" proposed="true">section 584(b)</cato:entity-ref>; and</text>
							</subparagraph>
              <subparagraph id="id973ebb0363c24427b1fc03b88e389579">
                <enum>(D)</enum>
                <text>in the case of a
				dispenser, having a valid license under State law.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="idfcfe82ac47064c95ae56d117bec5c256">
              <enum>(2)</enum>
              <header>Compressed
				medical gas</header>
              <text>The term <term>compressed medical gas</term> means
				any substance in its gaseous or cryogenic liquid form that meets medical purity
				standards and has application in a medical or homecare environment, including
				oxygen and nitrous oxide.</text>
						</paragraph>
            <paragraph id="id0DE960C30F5D4659AF50A28B7C172896">
              <enum>(3)</enum>
              <header>Dispenser</header>
              <text>The
				term <term>dispenser</term>—</text>
							<subparagraph id="id867DB2E332B64235BDB11DF0611DDB89">
                <enum>(A)</enum>
                <text>means a retail
				pharmacy, hospital pharmacy, a group of chain pharmacies under common ownership
				and control that do not act as a wholesale distributor, or any other person
				authorized by law to dispense or administer prescription drugs, and the
				affiliated warehouses or distribution centers of such entities under common
				ownership and control that do not act as a wholesale distributor; and</text>
							</subparagraph>
              <subparagraph id="idF2DAD3182D2941A496F0B699068ED4A4">
                <enum>(B)</enum>
                <text>does not include
				a person who only dispenses products to be used in animals in accordance with
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:a/p:5">section 512(a)(5)</cato:entity-ref>.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="idda6e5010dba747a1b2d8ecdd06b68e3d">
              <enum>(4)</enum>
              <header>Disposition</header>
              <text>The
				term <term>disposition</term>, with respect to a product within the possession
				or control of an entity, means the removal of such product from the
				pharmaceutical distribution supply chain, which may include disposal or return
				of the product for disposal or other appropriate handling and other actions
				such as retaining a sample of the product for further additional physical
				examination or laboratory analysis of the product by a manufacturer or
				regulatory or law enforcement agency.</text>
						</paragraph>
            <paragraph id="idfc8c6328ffab42028fe7be8dab64309d">
              <enum>(5)</enum>
              <header>Distribute or
				distribution</header>
              <text>The term <term>distribute</term> or
				<term>distribution</term> means the sale, purchase, trade, delivery, handling,
				storage, or receipt of a product.</text>
						</paragraph>
            <paragraph id="idA4556EC0B2CC41AF84B2BF988AE9948F">
              <enum>(6)</enum>
              <header>Exclusive
				distributor</header>
              <text>The term <term>exclusive distributor</term> means the
				wholesale distributor that directly purchased product from the manufacturer and
				is the sole distributor of that manufacturer's product to a subsequent
				wholesale distributor or dispenser.</text>
						</paragraph>
            <paragraph id="idB8542D170FD443EBBF73DC6D6E5D0930">
              <enum>(7)</enum>
              <header>Homogeneous
				case</header>
              <text>The term <term>homogeneous case</term> means a sealed case
				containing only product that has a single National Drug Code number belonging
				to a single lot.</text>
						</paragraph>
            <paragraph id="idcc29be85d8fb47eca661045e3e5c492a">
              <enum>(8)</enum>
              <header>Illegitimate
				product</header>
              <text>The term <term>illegitimate product</term> means a
				product for which credible evidence shows that the product—</text>
							<subparagraph id="idbdc9e75337b5485bb65e6274b048cade">
                <enum>(A)</enum>
                <text>is counterfeit,
				diverted, or stolen;</text>
							</subparagraph>
              <subparagraph id="idd54d466db0474169b9ccb4de2f0e0bef">
                <enum>(B)</enum>
                <text>is intentionally
				adulterated such that the product would result in serious adverse health
				consequences or death to humans;</text>
							</subparagraph>
              <subparagraph id="id67376b7d3cc540598383ede303182493">
                <enum>(C)</enum>
                <text>is the subject of
				a fraudulent transaction; or</text>
							</subparagraph>
              <subparagraph id="idb832a731104e4ee9904253db2236efa5">
                <enum>(D)</enum>
                <text>appears otherwise
				unfit for distribution such that the product could result in serious adverse
				health consequence or death to humans.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="idb7b0012b4a0f452a87274ee277cced57">
              <enum>(9)</enum>
              <header>Licensed</header>
              <text>The
				term <term>licensed</term> means—</text>
							<subparagraph id="ida8901217a7554e20bc566672ddf65844">
                <enum>(A)</enum>
                <text>in the case of a
				wholesale distributor, having a valid license under State law or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:583" proposed="true">section 583</cato:entity-ref>,
				in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:6" proposed="true">section 582(a)(6)</cato:entity-ref>;</text>
							</subparagraph>
              <subparagraph id="id8342cdba6825407eacd88c81de0a8e23">
                <enum>(B)</enum>
                <text>in the case of a
				third-party logistics provider, having a valid license under State law or
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584/ss:a/p:1" proposed="true">section 584(a)(1)</cato:entity-ref>, in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:7" proposed="true">section 582(a)(7)</cato:entity-ref>; and</text>
							</subparagraph>
              <subparagraph id="id8da2ce2d40f24370874be6bc0cf7188c">
                <enum>(C)</enum>
                <text>in the case of a
				dispenser, having a valid license under State law.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="idc2ba4fef09cd4a559c553eb6d5c67a4b">
              <enum>(10)</enum>
              <header>Manufacturer</header>
							<subparagraph id="id72745956D4AB4382BA6DD09567D01742">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>The term <term>manufacturer</term> means, with respect to
				a product—</text>
								<clause id="id1978b386d1d04192967f4ad8e8517513">
                  <enum>(i)</enum>
                  <text>a
				person that holds an application approved under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505">section 505</cato:entity-ref> or a license issued
				under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351">section 351 of the Public Health Service Act</cato:entity-ref> for such product, or if such
				product is not the subject of an approved application or license, the person
				who manufactured the product;</text>
								</clause>
                <clause id="id05f65ef9ea6e476a91c8c2ac150c3ad2">
                  <enum>(ii)</enum>
                  <text>a co-licensed
				partner of the person described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:10/sp:A/cl:i" proposed="true">clause (i)</cato:entity-ref> that obtains the product directly
				from the person described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:10/sp:A/cl:i" proposed="true">clause (i)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:10/sp:A/cl:ii" proposed="true">(ii)</cato:entity-ref>; or</text>
								</clause>
                <clause id="id3268b5f273094db6aa7a4be5e495209a">
                  <enum>(iii)</enum>
                  <text>an affiliate of
				a person described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:10/sp:A/cl:i" proposed="true">clause (i)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:10/sp:A/cl:iii" proposed="true">(iii)</cato:entity-ref> that receives the product directly
				from a person described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:10/sp:A/cl:i" proposed="true">clause (i)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:10/sp:A/cl:ii" proposed="true">(ii)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:10/sp:A/cl:iii" proposed="true">(iii)</cato:entity-ref>.</text>
								</clause>
              </subparagraph>
              <subparagraph id="id4131D0517CDE4E97936D6BB7483B4B2E">
                <enum>(B)</enum>
                <header>Affiliate</header>
                <text>For
				purposes of this paragraph, the term <term>affiliate</term> means a member of
				an affiliated group, as that term is defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code/s:1504/ss:a">section 1504(a) of the Internal
				Revenue Code</cato:entity-ref>.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="idbebe001ab3a74f3e8df7ad497703bcb1">
              <enum>(11)</enum>
              <header>Package</header>
							<subparagraph id="id103EE59DEDC041A792BA89C1798770C5">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>The term <term>package</term> means the smallest
				individual saleable unit of product for distribution by a manufacturer or
				repackager that is intended by the manufacturer for ultimate sale to the
				dispenser of such product.</text>
							</subparagraph>
              <subparagraph id="id191B8FE881A74B9790C10F1FCABEEAB6">
                <enum>(B)</enum>
                <header>Individual
				saleable unit</header>
                <text>For purposes of this paragraph, an <term>individual
				saleable unit</term> is the smallest container of product introduced into
				commerce by the manufacturer or repackager that is intended by the manufacturer
				or repackager for individual sale to a dispenser.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id279715e6549647d093eaa2da91dbbb9d">
              <enum>(12)</enum>
              <header>Prescription
				drug</header>
              <text>The term <term>prescription drug</term> means a drug for
				human use subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1">section 503(b)(1)</cato:entity-ref>.</text>
						</paragraph>
            <paragraph id="idf4eb5ac4cf4a4935abddcc3412b41714">
              <enum>(13)</enum>
              <header>Product</header>
              <text>The
				term <term>product</term> means a prescription drug in a finished dosage form
				for administration to a patient without substantial further manufacturing (such
				as capsules, tablets, and lyophilized products before reconstitution), but does
				not include blood or blood components intended for transfusion, radioactive
				drugs or radioactive biological products (as defined in section 600.3(ee) of
				title 21, Code of Federal Regulations) that are regulated by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="3100">Nuclear
				Regulatory Commission</cato:entity-ref> or by a State pursuant to an agreement with such
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="3100">Commission</cato:entity-ref> under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                  <cato:entity-ref entity-type="act" value="Atomic Energy Act of 1954/s:274">section 274 of the Atomic Energy Act of 1954</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/2021">
                    <cato:entity-ref entity-type="uscode" value="usc/42/2021">42 U.S.C. 2021</cato:entity-ref>
                  </external-xref>)</cato:entity>,
				or any compressed medical gas.</text>
						</paragraph>
            <paragraph id="id1372100e9d964a47a5e04237ca567317">
              <enum>(14)</enum>
              <header>Product
				identifier</header>
              <text>The term <term>product identifier</term> means a
				standardized graphic that includes, in both human-readable form and on a
				machine-readable data carrier that conforms to the standards developed by a
				widely recognized international standards development organization, the
				standardized numerical identifier, lot number, and expiration date of the
				product.</text>
						</paragraph>
            <paragraph id="idD8B19FBC402A4FA6A8C459D61FFF297D">
              <enum>(15)</enum>
              <header>Quarantine</header>
              <text>The
				term <term>quarantine</term> means the storage or identification of a product,
				to prevent distribution or transfer of the product, in a physically separate
				area clearly identified for such use or through other procedures such as
				automated designation.</text>
						</paragraph>
            <paragraph id="idfc1ae01e2a3e4b76b7d87951fdcf77f8">
              <enum>(16)</enum>
              <header>Repackager</header>
              <text>The
				term <term>repackager</term> means a person who owns or operates an
				establishment that repacks and relabels a product or package for further
				sale.</text>
						</paragraph>
            <paragraph id="id6e1ecf8ad846456ead6533e801b1a612">
              <enum>(17)</enum>
              <header>Return</header>
              <text>The
				term <term>return</term> means providing product to the authorized immediate
				trading partner from which such product was purchased, or to a returns
				processor or reverse logistics provider for handling of such product.</text>
						</paragraph>
            <paragraph id="id59513d18bd0a4ab4b7e19a68fe88cd80">
              <enum>(18)</enum>
              <header>Returns
				processor or reverse logistics provider</header>
              <text>The term <term>returns
				processor</term> or <term>reverse logistics provider</term> means a person who
				owns or operates an establishment that dispositions or otherwise processes
				saleable or nonsaleable product received from an authorized trading partner
				such that the product may be processed for credit to the purchaser,
				manufacturer, or seller or disposed of for no further distribution.</text>
						</paragraph>
            <paragraph id="ide2d7a0e74f584e609bfa1f628932608f">
              <enum>(19)</enum>
              <header>Specific
				patient need</header>
              <text>The term <term>specific patient need</term> refers
				to the transfer of a product from one pharmacy to another to fill a
				prescription for an identified patient. Such term does not include the transfer
				of a product from one pharmacy to another for the purpose of increasing or
				replenishing stock in anticipation of a potential need.</text>
						</paragraph>
            <paragraph id="id8b5cbdca10e24f7aa100de541ac01038">
              <enum>(20)</enum>
              <header>Standardized
				numerical identifier or SNI</header>
              <text>The term <term>standardized numerical
				identifier</term> or <quote>SNI</quote> means a set of numbers or characters
				used to uniquely identify each package or homogenous case that is composed of
				the National Drug Code that corresponds to the specific product (including the
				particular package configuration) combined with a unique alphanumeric serial
				number of up to 20 characters.</text>
						</paragraph>
            <paragraph id="id7a5be6ac9c594085ab9feab1952f47a5">
              <enum>(21)</enum>
              <header>Suspect
				product</header>
              <text>The term <term>suspect product</term> means a product for
				which there is reason to believe that such product—</text>
							<subparagraph id="id7e6716ca3f6748d4ac3ada3b0b802e3b">
                <enum>(A)</enum>
                <text>is potentially
				counterfeit, diverted, or stolen;</text>
							</subparagraph>
              <subparagraph id="id052cc2f672554e99bd71077b78088f5c">
                <enum>(B)</enum>
                <text>is potentially
				intentionally adulterated such that the product would result in serious adverse
				health consequences or death to humans;</text>
							</subparagraph>
              <subparagraph id="idfcfd88f1ce4945c09267b7de46142712">
                <enum>(C)</enum>
                <text>is potentially
				the subject of a fraudulent transaction; or</text>
							</subparagraph>
              <subparagraph id="id96e183e271b947669efec9532068d5de">
                <enum>(D)</enum>
                <text>appears otherwise
				unfit for distribution such that the product would result in serious adverse
				health consequences or death to humans.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="idad2a332b6e7b4d368be38907b0939cf0">
              <enum>(22)</enum>
              <header>Third-party
				logistics provider</header>
              <text>The term <term>third-party logistics
				provider</term> means an entity that provides or coordinates warehousing, or
				other logistics services of a product in interstate commerce on behalf of a
				manufacturer, wholesale distributor, or dispenser of a product, but does not
				take ownership of the product, nor have responsibility to direct the sale or
				disposition of the product.</text>
						</paragraph>
            <paragraph id="id20902c8261dd4b4b855f6743136f34b7">
              <enum>(23)</enum>
              <header>Trading
				partner</header>
              <text>The term <term>trading partner</term> means—</text>
							<subparagraph id="id75928a1a6dd748ac8fb9ea81e21491fd">
                <enum>(A)</enum>
                <text>a manufacturer,
				repackager, wholesale distributor, or dispenser from whom a manufacturer,
				repackager, wholesale distributor, or dispenser accepts direct ownership of a
				product or to whom a manufacturer, repackager, wholesale distributor, or
				dispenser transfers direct ownership of a product; or</text>
							</subparagraph>
              <subparagraph id="id1fb7169c63574c21afb9a8bd314338cb">
                <enum>(B)</enum>
                <text>a third-party
				logistics provider from whom a manufacturer, repackager, wholesale distributor,
				or dispenser accepts direct possession of a product or to whom a manufacturer,
				repackager, wholesale distributor, or dispenser transfers direct possession of
				a product.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="idc351f735afc24d65bf79a47cacc7d6b5">
              <enum>(24)</enum>
              <header>Transaction</header>
							<subparagraph id="id85e1fa0df95e4fdfa8cf504c40502c8a">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>The term <term>transaction</term> means the transfer of
				product between persons in which a change of ownership occurs.</text>
							</subparagraph>
              <subparagraph id="id59e38a9fcd4a4d6985d67b634959974e">
                <enum>(B)</enum>
                <header>Exemptions</header>
                <text>The
				term <term>transaction</term> does not include—</text>
								<clause id="id2ef68d4493674ec9938b2695ba9a1bc6">
                  <enum>(i)</enum>
                  <text>intracompany
				distribution of any product between members of an affiliated group (as defined
				in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:1504/ss:a">
                      <external-xref legal-doc="usc" parsable-cite="usc/26/1504">section 1504(a)</external-xref> of the Internal Revenue Code of 1986</cato:entity-ref>);</text>
								</clause>
                <clause id="ide2c942b3b82a4893b51633a7513ca608">
                  <enum>(ii)</enum>
                  <text>the distribution
				of a product among hospitals or other health care entities that are under
				common control;</text>
								</clause>
                <clause id="id276e3165050941f28309435d6e25dc44">
                  <enum>(iii)</enum>
                  <text>the
				distribution of a product for emergency medical reasons including a public
				health emergency declaration pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319">section 319 of the Public Health
				Service Act</cato:entity-ref>, except that a drug shortage not caused by a public health
				emergency shall not constitute an emergency medical reason;</text>
								</clause>
                <clause id="idfb8d47894a554d0d926e2b0a26d0440d">
                  <enum>(iv)</enum>
                  <text>the dispensing
				of a product pursuant to a valid prescription executed in accordance with
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1">section 503(b)(1)</cato:entity-ref>;</text>
								</clause>
                <clause id="id4dad1453ca81467481f6587e20bb18a5">
                  <enum>(v)</enum>
                  <text>the distribution
				of product samples by a manufacturer or a licensed wholesale distributor in
				accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:d">section 503(d)</cato:entity-ref>;</text>
								</clause>
                <clause id="idec7611c0f765471485047fc0ba58336e">
                  <enum>(vi)</enum>
                  <text>the distribution
				of blood or blood components intended for transfusion;</text>
								</clause>
                <clause id="id3a415585c57d40f39f49ff11d8f7b69d">
                  <enum>(vii)</enum>
                  <text>the
				distribution of minimal quantities of product by a licensed retail pharmacy to
				a licensed practitioner for office use;</text>
								</clause>
                <clause id="id529815ee76ff4d7082e14d52fd73e4d5">
                  <enum>(viii)</enum>
                  <text>the sale,
				purchase, or trade of a drug or an offer to sell, purchase, or trade a drug by
				a charitable organization described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1954/s:501/ss:c/p:3">section 501(c)(3) of the Internal
				Revenue Code of 1954</cato:entity-ref> to a nonprofit affiliate of the organization to the extent
				otherwise permitted by law;</text>
								</clause>
                <clause id="ida15ad14a23864e7995409f4a74798dd9">
                  <enum>(ix)</enum>
                  <text>the distribution
				of a product pursuant to the sale or merger of a pharmacy or pharmacies or a
				wholesale distributor or wholesale distributors, except that any records
				required to be maintained for the product shall be transferred to the new owner
				of the pharmacy or pharmacies or wholesale distributor or wholesale
				distributors;</text>
								</clause>
                <clause id="id4e6a280bfd364451b255337948958c55">
                  <enum>(x)</enum>
                  <text>the dispensing of
				a product approved under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:b">section 512(b)</cato:entity-ref>;</text>
								</clause>
                <clause id="idecf8e564a4c7441e89c3c3340a8bc58b">
                  <enum>(xi)</enum>
                  <text>products
				transferred to or from any facility that is licensed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="3100">Nuclear Regulatory
				Commission</cato:entity-ref> or by a State pursuant to an agreement with such <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="3100">Commission</cato:entity-ref> under
				<cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                      <cato:entity-ref entity-type="act" value="Atomic Energy Act of 1954/s:274">section 274 of the Atomic Energy Act of 1954</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/2021">
                        <cato:entity-ref entity-type="uscode" value="usc/42/2021">42 U.S.C. 2021</cato:entity-ref>
                      </external-xref>)</cato:entity>;</text>
								</clause>
                <clause id="idf7f949528f51402884ea9424109fc14a">
                  <enum>(xii)</enum>
                  <text>a combination
				product that is—</text>
									<subclause id="id856de6da470943959c08797305f7ab70">
                    <enum>(I)</enum>
                    <text>a product
				comprised of a device and 1 or more other regulated components (such as a
				drug/device, biologic/device, or drug/device/biologic) that are physically,
				chemically, or otherwise combined or mixed and produced as a single
				entity;</text>
									</subclause>
                  <subclause id="ide5c89ee4654d40a0aae823beb98e7628">
                    <enum>(II)</enum>
                    <text>2 or more
				separate products packaged together in a single package or as a unit and
				comprised of a drug and device products or device and biological product;
				or</text>
									</subclause>
                  <subclause id="idad73efd1cadb4a2f8be5e7f2926a6e1e">
                    <enum>(III)</enum>
                    <text>2 or more
				finished medical devices plus one or more drug or biological products which are
				packaged together in what is referred to as a <quote>medical convenience
				kit</quote> as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:24/sp:B/cl:xiii" proposed="true">clause (xiii)</cato:entity-ref>;</text>
									</subclause>
                </clause>
                <clause id="idc093ab22cec54016b0dc290e53ea8c9f">
                  <enum>(xiii)</enum>
                  <text>the
				distribution of a collection of finished medical devices or a collection of
				finished drug or biological products assembled in kit form strictly for the
				convenience of the purchaser or user (to be known as a <quote>medical
				convenience kit</quote>) if—</text>
									<subclause id="id6f29a6f1b784436cba2b3894d209d21f">
                    <enum>(I)</enum>
                    <text>the medical
				convenience kit is assembled in an establishment that is registered with the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> as a device manufacturer in accordance with
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:510/ss:b/p:2">section 510(b)(2)</cato:entity-ref>;</text>
									</subclause>
                  <subclause id="id21c3831654fb4067b0d6f408c19ab0e2">
                    <enum>(II)</enum>
                    <text>the person who
				manufactures a medical convenience kit purchased the product contained in the
				medical convenience kit directly from the pharmaceutical manufacturer or from a
				wholesale distributor that purchased the product directly from the
				pharmaceutical manufacturer;</text>
									</subclause>
                  <subclause id="id50074e2e76a14725bbf37b6cb1f13c61">
                    <enum>(III)</enum>
                    <text>the person who
				manufactures a medical convenience kit does not alter the primary container or
				label of the product as purchased from the manufacturer or wholesale
				distributor;</text>
									</subclause>
                  <subclause id="id2f76cb38f136405ba964b848b6e0e257">
                    <enum>(IV)</enum>
                    <text>the medical
				convenience kit does not contain a controlled substance that appears in a
				schedule contained in the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Comprehensive Drug Abuse Prevention and Control Act of 1970">Comprehensive Drug Abuse Prevention and Control Act
				of 1970</cato:entity-ref>; and</text>
									</subclause>
                  <subclause commented="no" id="id67cc18d501304120956f2a1ae44e2730">
                    <enum>(V)</enum>
                    <text>the products
				contained in the medical convenience kit are—</text>
										<item commented="no" id="id9946b07719bd491a882bc04a701012c6">
                      <enum>(aa)</enum>
                      <text>intravenous
				solutions intended for the replenishment of fluids and electrolytes;</text>
										</item>
                    <item commented="no" id="id83169e7b0dc34d0d9112dcd733481958">
                      <enum>(bb)</enum>
                      <text>products
				intended to maintain the equilibrium of water and minerals in the body;</text>
										</item>
                    <item commented="no" id="ida8a7001d46c84fd48501fbb7545b0ddf">
                      <enum>(cc)</enum>
                      <text>products
				intended for irrigation or reconstitution;</text>
										</item>
                    <item commented="no" id="id447a00837bde47fcbf3b19d7dae01d8d">
                      <enum>(dd)</enum>
                      <text>anesthetics;</text>
										</item>
                    <item commented="no" id="id4f31ae30b6c54ccfa81fb2f8829e29b8">
                      <enum>(ee)</enum>
                      <text>anticoagulants;</text>
										</item>
                    <item commented="no" id="id415e5434fcfe423aa0a2e65787aca2ca">
                      <enum>(ff)</enum>
                      <text>vasopressors;
				or</text>
										</item>
                    <item commented="no" id="idee2eb92470f94d32ac022d92f7f81ca1">
                      <enum>(gg)</enum>
                      <text>sympathicomimetics;</text>
										</item>
                  </subclause>
                </clause>
                <clause id="id69f27ef9ecb64b11adc6793ee07484d8">
                  <enum>(xiv)</enum>
                  <text>the
				distribution of an intravenous product that, by its formulation, is intended
				for the replenishment of fluids and electrolytes (such as sodium, chloride, and
				potassium) or calories (such as dextrose and amino acids);</text>
								</clause>
                <clause id="id12530294cc164d36821772622fc376d8">
                  <enum>(xv)</enum>
                  <text>the distribution
				of an intravenous product used to maintain the equilibrium of water and
				minerals in the body, such as dialysis solutions;</text>
								</clause>
                <clause id="id70cce742ef304264894a443073c30383">
                  <enum>(xvi)</enum>
                  <text>the
				distribution of a product that is intended for irrigation or reconstitution, or
				sterile water, whether intended for such purposes or for injection;</text>
								</clause>
                <clause id="idf127af1045fe4ae6be819ee48bdee7f7">
                  <enum>(xvii)</enum>
                  <text>the
				distribution of compressed medical gas; or</text>
								</clause>
                <clause id="idA050B63788504E278CB043049EBD6BEE">
                  <enum>(xviii)</enum>
                  <text>the
				distribution or sale of any licensed product under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351">section 351 of the Public
				Health Service Act</cato:entity-ref> that meets the definition of a device under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:201/ss:h">section
				201(h)</cato:entity-ref>.</text>
								</clause>
              </subparagraph>
            </paragraph>
            <paragraph id="id8f6a79e496e74f0a95882c4c19f97a52">
              <enum>(25)</enum>
              <header>Transaction
				history</header>
              <text>The term <term>transaction history</term> means a
				statement in paper or electronic form, including the transaction information
				for each prior transaction going back to the manufacturer of the
				product.</text>
						</paragraph>
            <paragraph id="idaa900461f34c40eb9fc14b16e596cadd">
              <enum>(26)</enum>
              <header>Transaction
				information</header>
              <text>The term <term>transaction information</term>
				means—</text>
							<subparagraph id="idca98550e56a645c7b098fe9278326569">
                <enum>(A)</enum>
                <text>the proprietary
				or established name or names of the product;</text>
							</subparagraph>
              <subparagraph id="id386a30da80c0403880676fa3c3e4c469">
                <enum>(B)</enum>
                <text>the strength and
				dosage form of the product;</text>
							</subparagraph>
              <subparagraph id="id7615f0999be64861956cf8426c3e698d">
                <enum>(C)</enum>
                <text>the National Drug
				Code number of the product;</text>
							</subparagraph>
              <subparagraph id="id0a077f0485af4fd6993f8de504062c45">
                <enum>(D)</enum>
                <text>the container
				size;</text>
							</subparagraph>
              <subparagraph id="ide94175caa17e44ce9c9c272738f14f1b">
                <enum>(E)</enum>
                <text>the number of
				containers;</text>
							</subparagraph>
              <subparagraph id="id82a3c8680b2b44cfacd679c332d9af65">
                <enum>(F)</enum>
                <text>the lot number of
				the product;</text>
							</subparagraph>
              <subparagraph id="id7efd3f6ccf5545ae834fd657660d584c">
                <enum>(G)</enum>
                <text>the date of the
				transaction;</text>
							</subparagraph>
              <subparagraph id="id27b76abda7c1484f98ff846bc709591f">
                <enum>(H)</enum>
                <text>the date of the
				shipment, if different from the date of the transaction;</text>
							</subparagraph>
              <subparagraph id="ide58569b4c2914634a89d62d17b7992ca">
                <enum>(I)</enum>
                <text>the business name
				and address of the person from whom ownership is being transferred; and</text>
							</subparagraph>
              <subparagraph id="id85c9627775484111bd479714c4ae17fb">
                <enum>(J)</enum>
                <text>the business name
				and address of the person to whom ownership is being transferred.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id356d828b4997401b934b2a5e59241792">
              <enum>(27)</enum>
              <header>Transaction
				statement</header>
              <text>The <term>transaction statement</term> is a statement,
				in paper or electronic form, that the entity transferring ownership in a
				transaction—</text>
							<subparagraph id="id18a4efa686ad445f85b79cc6c4f80097">
                <enum>(A)</enum>
                <text>is authorized as
				required under the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>;</text>
							</subparagraph>
              <subparagraph id="id67a0a2fb0bb14a4a9b6ffcadb77d469a">
                <enum>(B)</enum>
                <text>received the
				product from a person that is authorized as required under the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>;</text>
							</subparagraph>
              <subparagraph id="id02781730D561448CB810679D29C5D390">
                <enum>(C)</enum>
                <text>received
				transaction information and a transaction statement from the prior owner of the
				product, as required under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582" proposed="true">section 582</cato:entity-ref>;</text>
							</subparagraph>
              <subparagraph id="idcac2d913ce84400db604f862b410483c">
                <enum>(D)</enum>
                <text>did not knowingly
				ship a suspect or illegitimate product;</text>
							</subparagraph>
              <subparagraph id="idCDA67D75D0CF4EA4A7B1B2B5539EA460">
                <enum>(E)</enum>
                <text>had systems and
				processes in place to comply with verification requirements under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582" proposed="true">section
				582</cato:entity-ref>;</text>
							</subparagraph>
              <subparagraph id="idea18980e94fb47b7b3a8c9f801099fbf">
                <enum>(F)</enum>
                <text>did not knowingly
				provide false transaction information; and</text>
							</subparagraph>
              <subparagraph id="id821bbce9d3ae4cfa969060d6c124b999">
                <enum>(G)</enum>
                <text>did not knowingly
				alter the transaction history.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id0fb40f67e3b04906a5268574b4d63b0b">
              <enum>(28)</enum>
              <header>Verification
				or verify</header>
              <text>The term <term>verification</term> or
				<quote>verify</quote> means determining whether the product identifier affixed
				to, or imprinted upon, a package or homogeneous case corresponds to the
				standardized numerical identifier or lot number, and expiration date assigned
				to the product by the manufacturer or the repackager, as applicable in
				accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582" proposed="true">section 582</cato:entity-ref>.</text>
						</paragraph>
            <paragraph commented="no" id="id1a6ab3c16a3341fbae288693e0fd2a42">
              <enum>(29)</enum>
              <header>Wholesale
				distributor</header>
              <text>The term <term>wholesale distributor</term> means a
				person (other than a manufacturer, a manufacturer's co-licensed partner, a
				third-party logistics provider, or repackager) engaged in wholesale
				distribution (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:4" proposed="true">section 503(e)(4)</cato:entity-ref>, as amended by the
				<short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                </short-title>).</text>
						</paragraph>
          </section>
          <section id="id0e96c13b1e944d0283468014a8ff4603">
            <enum>582.</enum>
            <header>Requirements</header>
						<subsection id="idc9e4612b030e4b1980d0f0db2666aabb">
              <enum>(a)</enum>
              <header>In
				general</header>
							<paragraph id="idcad420f79ecc427da64d5d4f201df2f3">
                <enum>(1)</enum>
                <header>Other
				activities</header>
                <text>Each manufacturer, repackager, wholesale distributor,
				third-party logistics provider, and dispenser shall comply with the
				requirements set forth in this section with respect to the role of such
				manufacturer, repackager, wholesale distributor, third-party logistics
				provider, or dispenser in a transaction involving product. If an entity meets
				the definition of more than one of the entities listed in the preceding
				sentence, such entity shall comply with all applicable requirements in this
				section, but shall not be required to duplicate requirements.</text>
							</paragraph>
              <paragraph id="id37f83c884ab54f1ab1fb5e22d634fd5f">
                <enum>(2)</enum>
                <header>Initial
				standards</header>
								<subparagraph id="idD874702E61B34786BA69B2EA8177F5AF">
                  <enum>(A)</enum>
                  <header>In
				general</header>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall, in consultation with other
				appropriate Federal officials, manufacturers, repackagers, wholesale
				distributors, third-party logistics providers, dispensers, and other
				pharmaceutical distribution supply chain stakeholders, issue a draft guidance
				document that establishes standards for the interoperable exchange of
				transaction information for compliance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a" proposed="true">subsections (a)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:b" proposed="true">(b)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c" proposed="true">(c)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:d" proposed="true">(d)</cato:entity-ref>,
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e" proposed="true">(e)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:f" proposed="true">(f)</cato:entity-ref>. The standards established under this paragraph shall take into
				consideration the standards established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505D">section 505D</cato:entity-ref> and shall comply
				with a form and format developed by a widely recognized international standards
				development organization.</text>
								</subparagraph>
                <subparagraph id="id74B3639C825C49B5A31BD50BB211E381">
                  <enum>(B)</enum>
                  <header>Public
				input</header>
                  <text>Prior to issuing the draft guidance under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>,
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall gather comments and information from stakeholders and
				maintain such comments and information in a public docket for at least 60 days
				prior to issuing such guidance.</text>
								</subparagraph>
                <subparagraph id="id834853DFD1374AE0B59897AB12CD3B59">
                  <enum>(C)</enum>
                  <header>Publication</header>
                  <text>The
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall publish the standards established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> not
				later than 1 year after the date of enactment of the
				<short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                    </short-title>.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="id52847607be7f4567b1224facddbf1115">
                <enum>(3)</enum>
                <header>Waivers,
				exceptions, and exemptions</header>
								<subparagraph id="idb4be36e379a34b86bfdfb4acd69f670e">
                  <enum>(A)</enum>
                  <header>In
				general</header>
                  <text>Not later than 2 years after the date of enactment of the
				<short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                    </short-title>,
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall, by guidance—</text>
									<clause id="id046aa406c23a458fb0e4f933f4c59e03">
                    <enum>(i)</enum>
                    <text>establish a
				process by which an authorized manufacturer, repackager, wholesale distributor,
				or dispenser may request a waiver from any of the requirements set forth in
				this section if the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines that such requirements would result in
				an undue economic hardship or for emergency medical reasons, including a public
				health emergency declaration pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319">section 319 of the Public Health
				Service Act</cato:entity-ref>;</text>
									</clause>
                  <clause id="id0c0475ac0bdf4d13b6f461fbbff7ec5e">
                    <enum>(ii)</enum>
                    <text>establish a
				process by which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines exceptions, and a process through
				which a manufacturer or repackager may request such an exception, to the
				requirements relating to product identifiers if a product is packaged in a
				container too small or otherwise unable to accommodate a label with sufficient
				space to bear the information required for compliance with this section;
				and</text>
									</clause>
                  <clause id="idd6f921d9e6cd486c963d2ee9c9b599a2">
                    <enum>(iii)</enum>
                    <text>establish a
				process by which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may determine other products or transactions
				that shall be exempt from the requirements of this section.</text>
									</clause>
                </subparagraph>
                <subparagraph id="idfaceb20ff9fa402585c406c5e3cf8053">
                  <enum>(B)</enum>
                  <header>Content</header>
                  <text>The
				guidance issued under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:3/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> shall include a process for the biennial
				review and renewal of such waivers, exceptions, and exemptions, as
				applicable.</text>
								</subparagraph>
                <subparagraph commented="no" id="idEAF57E4A3C194DF6858F8502752DE6AA">
                  <enum>(C)</enum>
                  <header>Process</header>
                  <text>In
				issuing the guidance under this section, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall provide an
				effective date that is not later than 180 days prior to the date on which
				manufacturers are required to affix or imprint a product identifier to each
				package and homogenous case of product intended to be introduced in a
				transaction into commerce consistent with this section.</text>
								</subparagraph>
              </paragraph>
              <paragraph commented="no" id="id5e1f761a44c44712a4d5159f322481c2">
                <enum>(4)</enum>
                <header>Self-executing
				requirements</header>
                <text>Except where otherwise specified, the requirements
				of this section may be enforced without further regulations or guidance from
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>.</text>
							</paragraph>
              <paragraph id="id73e72de97f104e46a3fe6e56a012c75b">
                <enum>(5)</enum>
                <header>Grandfathering
				product</header>
								<subparagraph id="id4852fe7bb9a649b3b30e516a0cd2ff63">
                  <enum>(A)</enum>
                  <header>Product
				identifier</header>
                  <text>Not later than 2 years after the date of enactment of
				the <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                    </short-title>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall finalize guidance specifying whether and
				under what circumstances product that is not labeled with a product identifier
				and that is in the pharmaceutical distribution supply chain at the time of the
				effective date of the requirements of this section shall be exempted from the
				requirements of this section.</text>
								</subparagraph>
                <subparagraph id="id83b96e7662564d708bdc0ee29e6e253c">
                  <enum>(B)</enum>
                  <header>Tracing</header>
                  <text>For
				a product that entered the pharmaceutical distribution supply chain prior to
				the date that is 1 year after the date of enactment of the
				<short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                    </short-title>—</text>
									<clause id="id834761bfd4c2437eb733525f32c897d0">
                    <enum>(i)</enum>
                    <text>authorized
				trading partners shall be exempt from providing transaction information as
				required under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:1/sp:A/cl:i" proposed="true">subsections (b)(1)(A)(i)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii" proposed="true">(c)(1)(A)(ii)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:1/sp:A/cl:ii" proposed="true">(d)(1)(A)(ii)</cato:entity-ref>, and
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:1/sp:A/cl:ii" proposed="true">(e)(1)(A)(ii)</cato:entity-ref> of this section;</text>
									</clause>
                  <clause id="id08de44577164496388838409419e73de">
                    <enum>(ii)</enum>
                    <text>transaction
				history required under this section shall begin with the owner of such product
				on such date; and</text>
									</clause>
                  <clause id="id5c92353bdc27481598bcb8e51f402dbe">
                    <enum>(iii)</enum>
                    <text>the owners of
				such product on such date shall be exempt from asserting receipt of transaction
				information and transaction statement from the prior owner as required under
				this section.</text>
									</clause>
                </subparagraph>
              </paragraph>
              <paragraph id="idf1685d0360bc4f89a6eb496387e301ae">
                <enum>(6)</enum>
                <header>Wholesale
				distributor licenses</header>
                <text>Notwithstanding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:9/sp:A" proposed="true">section 581(9)(A)</cato:entity-ref>, until the
				effective date of the wholesale distributor licensing regulations under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:583" proposed="true">section
				583</cato:entity-ref>, the term <term>licensed</term> or <term>authorized</term>, as it relates
				to a wholesale distributor with respect to prescription drugs, shall mean a
				wholesale distributor with a valid license under State law.</text>
							</paragraph>
              <paragraph id="id8258bd50035549d59bed3326d55cec29">
                <enum>(7)</enum>
                <header>Third-party
				logistics provider licenses</header>
                <text>Until the effective date of the
				third-party logistics provider licensing regulations under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584" proposed="true">section 584</cato:entity-ref>, a
				third-party logistics provider shall be considered <term>licensed</term> under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:9/sp:B" proposed="true">section 581(9)(B)</cato:entity-ref> unless the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> has made a finding that the third-party
				logistics provider does not utilize good handling and distribution practices
				and publishes notice thereof.</text>
							</paragraph>
              <paragraph id="ida561b5660ce642bc97de9c1982459ce6">
                <enum>(8)</enum>
                <header>Label
				changes</header>
                <text>Changes made to package labels solely to incorporate the
				product identifier may be submitted to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> in the annual report of an
				establishment, in accordance with section 314.70(d) of chapter 21, Code of
				Federal Regulations (or any successor regulation).</text>
							</paragraph>
              <paragraph id="idAFDA258E0050423DB77A637A2D87141B">
                <enum>(9)</enum>
                <header>Product
				identifiers</header>
                <text>With respect to any requirement relating to product
				identifiers under this subchapter—</text>
								<subparagraph id="id41C32D7747534196A40C2C7C33E23807">
                  <enum>(A)</enum>
                  <text>unless the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> allows, through guidance, the use of other technologies for data
				instead of or in addition to the technologies described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:9/sp:A/cl:i" proposed="true">clauses (i)</cato:entity-ref> and
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:9/sp:A/cl:ii" proposed="true">(ii)</cato:entity-ref>, the applicable data—</text>
									<clause id="idF7130F0239B747A5B0EC19BCE899AAA2">
                    <enum>(i)</enum>
                    <text>shall be included
				in a 2-dimensional data matrix barcode when affixed to, or imprinted upon, a
				package; or</text>
									</clause>
                  <clause id="id14EB58A5C8EB486DB8422EE6B2CA09EA">
                    <enum>(ii)</enum>
                    <text>shall be
				included in a linear or 2-dimensional data matrix barcode when affixed to, or
				imprinted upon, a homogeneous case; and</text>
									</clause>
                </subparagraph>
                <subparagraph id="idF27288400FD640368827999A6BDF61CC">
                  <enum>(B)</enum>
                  <text>verification of
				the product identifier may occur by using human-readable or machine-readable
				methods.</text>
								</subparagraph>
              </paragraph>
            </subsection>
            <subsection id="id553feec93e3b45b3b3734a3340de56fc">
              <enum>(b)</enum>
              <header>Manufacturer
				requirements</header>
							<paragraph id="id91fc923ed7e648498b928e6c0b49d7ce">
                <enum>(1)</enum>
                <header>Product
				tracing</header>
								<subparagraph id="idcf0caf84a81e432b974673aa173a68e2">
                  <enum>(A)</enum>
                  <header>In
				general</header>
                  <text>Beginning not later than 1 year after the date of
				enactment of the <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                    </short-title>, a manufacturer shall—</text>
									<clause id="id9e261d132f1d4b3c930003ab9b27a6dc">
                    <enum>(i)</enum>
                    <text>prior to, or at
				the time of, each transaction in which such manufacturer transfers—</text>
										<subclause id="idF5662C317DEA463DBD2ACC4B3DA7A61A">
                      <enum>(I)</enum>
                      <text>ownership of a
				product, provide the subsequent recipient with transaction history, transaction
				information, and a transaction statement; or</text>
										</subclause>
                    <subclause id="idF980054B524D4D8A9A969FD2A059EA20">
                      <enum>(II)</enum>
                      <text>possession of a
				product to a third-party logistics provider for the purpose of transferring
				ownership as part of a transaction to a subsequent recipient, provide to the
				third-party logistics provider the transaction history, transaction
				information, and a transaction statement for such transaction to a subsequent
				recipient; and</text>
										</subclause>
                  </clause>
                  <clause id="id3afc991548c148dca90a0351ec16f825">
                    <enum>(ii)</enum>
                    <text>maintain the
				transaction information, transaction history, and transaction statement for
				each transaction for not less than 6 years after the date of the
				transaction.</text>
									</clause>
                </subparagraph>
                <subparagraph id="id3de29356dea54f05af5a8c31833eef14">
                  <enum>(B)</enum>
                  <header>Requests for
				information</header>
                  <text>Upon a request by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or other appropriate
				Federal or State official, in the event of a recall or for the purpose of
				investigating a suspect product or an illegitimate product, a manufacturer
				shall, not later than 24 hours after receiving the request or in other such
				reasonable time as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, based on the circumstances of
				the request, provide the applicable transaction information, transaction
				history, and transaction statement for the product.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="id0991a0019e78419d9db94f0592982e54">
                <enum>(2)</enum>
                <header>Product
				identifier</header>
                <text>Beginning not later than 4 years after the date of
				enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>, a manufacturer shall affix or imprint a product identifier
				to each package and homogenous case of a product intended to be introduced in a
				transaction into commerce. Such manufacturer shall maintain the product
				identifier information for such product for not less than 6 years after the
				date of the transaction.</text>
							</paragraph>
              <paragraph id="id4c503ff6b1554e29bad33aa8f71512cc">
                <enum>(3)</enum>
                <header>Authorized
				trading partners</header>
                <text>Beginning not later than 1 year after the date
				of enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain
				Security Act</cato:entity-ref>
                  </short-title>, the trading partners of a manufacturer may be only
				authorized trading partners.</text>
							</paragraph>
              <paragraph id="ida135ec28306d410986c839ace0c9dac8">
                <enum>(4)</enum>
                <header>Verification</header>
                <text>Beginning
				not later than 1 year after the date of enactment of the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                  </short-title>,
				a manufacturer shall have systems in place to enable the manufacturer to comply
				with the following requirements:</text>
								<subparagraph id="ide4ad32a0131c45268049a3f603d722d4">
                  <enum>(A)</enum>
                  <header>Suspect
				product</header>
									<clause id="id97540dee73fd4ba6b63bc45d731ed7a2">
                    <enum>(i)</enum>
                    <header>In
				general</header>
                    <text>Upon making a determination that a product in the
				possession or control of the manufacturer is a suspect product, or upon
				receiving a request for verification from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> that has made a
				determination that a product within the possession or control of a manufacturer
				is a suspect product, a manufacturer shall—</text>
										<subclause id="idc52df06835c747ba9c5dbefc239a18cb">
                      <enum>(I)</enum>
                      <text>quarantine such
				product within the possession or control of the manufacturer from product
				intended for distribution until such product is cleared or dispositioned;
				and</text>
										</subclause>
                    <subclause id="idcd6164f025f04a789daa9a21c3aa98ea">
                      <enum>(II)</enum>
                      <text>promptly conduct
				an investigation in coordination with trading partners, as applicable, to
				determine whether the product is an illegitimate product, which shall include
				validating any applicable transaction history and transaction information in
				the possession of the manufacturer and otherwise investigating to determine
				whether the product is an illegitimate product, and, beginning 4 years after
				the date of enactment of the <short-title>
                          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply
				Chain Security Act</cato:entity-ref>
                        </short-title>, verifying the product at the package
				level.</text>
										</subclause>
                  </clause>
                  <clause id="id4ac0a4b3da8f4f1ab95bad0736a31bce">
                    <enum>(ii)</enum>
                    <header>Cleared
				product</header>
                    <text>If the manufacturer makes the determination that a
				suspect product is not an illegitimate product, the manufacturer shall promptly
				notify the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, if applicable, of such determination and such product may
				be further distributed.</text>
									</clause>
                  <clause id="id8d0dc3cc676242339204f009bbb45641">
                    <enum>(iii)</enum>
                    <header>Records</header>
                    <text>A
				manufacturer shall keep records of the investigation of a suspect product for
				not less than 6 years after the conclusion of the investigation.</text>
									</clause>
                </subparagraph>
                <subparagraph id="idcf29cf9c3db041639c11f20ee933c0b8">
                  <enum>(B)</enum>
                  <header>Illegitimate
				product</header>
									<clause id="idf7b725a1c7674924a67743b1c6c5d344">
                    <enum>(i)</enum>
                    <header>In
				general</header>
                    <text>Upon determining that a product in the possession or
				control of a manufacturer is an illegitimate product, the manufacturer shall,
				in a manner consistent with the systems and processes of such
				manufacturer—</text>
										<subclause id="id64b0b7d268474605a465e170691fc54c">
                      <enum>(I)</enum>
                      <text>quarantine such
				product within the possession or control of the manufacturer from product
				intended for distribution until such product is dispositioned;</text>
										</subclause>
                    <subclause id="idd7e05f9dee2d489d91c8086cb7004fbe">
                      <enum>(II)</enum>
                      <text>disposition the
				illegitimate product within the possession or control of the
				manufacturer;</text>
										</subclause>
                    <subclause id="id1e4945baf7a248568cf7f9198fd16199">
                      <enum>(III)</enum>
                      <text>take reasonable
				and appropriate steps to assist a trading partner to disposition an
				illegitimate product not in the possession or control of the manufacturer;
				and</text>
										</subclause>
                    <subclause id="idC60A629998314534871225BAA7F01C81">
                      <enum>(IV)</enum>
                      <text>retain a sample
				of the product for further physical examination or laboratory analysis of the
				product by the manufacturer or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> (or other appropriate Federal or State
				official) upon request by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> (or other appropriate Federal or State
				official), as necessary and appropriate.</text>
										</subclause>
                  </clause>
                  <clause id="idc715e2ffe9ce41cd8ce57354ce19c4da">
                    <enum>(ii)</enum>
                    <header>Making a
				notification</header>
										<subclause id="idb8c5c5991bd2411298893e2736c84152">
                      <enum>(I)</enum>
                      <header>Illegitimate
				product</header>
                      <text>Upon determining that a product in the possession or
				control of the manufacturer is an illegitimate product, the manufacturer shall
				notify the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and all immediate trading partners that the manufacturer
				has reason to believe may have received such illegitimate product of such
				determination not later than 24 hours after making such determination.</text>
										</subclause>
                    <subclause id="idba3b3158b0034818b19ceeb7ba05491f">
                      <enum>(II)</enum>
                      <header>High risk of
				illegitimacy</header>
                      <text>A manufacturer shall notify the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and
				immediate trading partners that the manufacturer has reason to believe may have
				in the trading partner’s possession a product manufactured by, or purported to
				be a product manufactured by, the manufacturer not later than 24 hours after
				determining or being notified by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or a trading partner that there
				is a high risk that such product is an illegitimate product. For purposes of
				this subclause, a <quote>high risk</quote> may include a specific high-risk
				that could increase the likelihood that illegitimate product will enter the
				pharmaceutical distribution supply chain and other high risks as determined by
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> in guidance pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i" proposed="true">subsection (i)</cato:entity-ref>.</text>
										</subclause>
                  </clause>
                  <clause id="id401f856c33254aa6b8f1610eac275006">
                    <enum>(iii)</enum>
                    <header>Responding to
				a notification</header>
                    <text>Upon the receipt of a notification from the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or a trading partner that a determination has been made that a
				product is an illegitimate product, a manufacturer shall identify all
				illegitimate product subject to such notification that is in the possession or
				control of the manufacturer, including any product that is subsequently
				received, and shall perform the activities described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:4/sp:A" proposed="true">subparagraph
				(A)</cato:entity-ref>.</text>
									</clause>
                  <clause id="idF374CE6063C54F4885382FBD4295A95F">
                    <enum>(iv)</enum>
                    <header>Terminating a
				notification</header>
                    <text>Upon making a determination, in consultation with
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, that a notification is no longer necessary, a manufacturer shall
				promptly notify immediate trading partners that the manufacturer notified
				pursuant to clause (ii) that such notification has been terminated.</text>
									</clause>
                  <clause id="id5206f276e6bc4122921a1e33e101954b">
                    <enum>(v)</enum>
                    <header>Records</header>
                    <text>A
				manufacturer shall keep records of the disposition of an illegitimate product
				for not less than 6 years after the conclusion of the disposition.</text>
									</clause>
                </subparagraph>
                <subparagraph id="idd67bae2948704c99a2907228a0dd8dad">
                  <enum>(C)</enum>
                  <header>Requests for
				verification</header>
                  <text>Beginning 4 years after the date of enactment of the
				<short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                    </short-title>,
				upon receiving a request for verification from an authorized repackager,
				wholesale distributor, or dispenser that is in possession or control of a
				product they believe to be manufactured by such manufacturer, a manufacturer
				shall, not later than 24 hours after receiving the verification request or in
				other such reasonable time as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, based on the
				circumstances of the request, notify the person making the request whether the
				product identifier, including the standard numeric identifier, that is the
				subject of the request corresponds to the product identifier affixed or
				imprinted by the manufacturer. If a manufacturer responding to a verification
				request identifies a product identifier that does not correspond to that
				affixed or imprinted by the manufacturer, the manufacturer shall treat such
				product as suspect product and conduct an investigation as described in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:4/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>. If the manufacturer has reason to believe the product is an
				illegitimate product, the manufacturer shall advise the person making the
				request of such belief at the time such manufacturer responds to the
				verification request.</text>
								</subparagraph>
                <subparagraph id="id0a9ae00875004171b5c5805eecd72591">
                  <enum>(D)</enum>
                  <header>Electronic
				database</header>
                  <text>A manufacturer may satisfy the requirements of this
				paragraph by developing a secure electronic database or utilizing a secure
				electronic database developed or operated by another entity. The owner of such
				database shall establish the requirements and processes to respond to requests
				and may provide for data access to other members of the pharmaceutical
				distribution supply chain, as appropriate. The development and operation of
				such a database shall not relieve a manufacturer of the requirement under this
				paragraph to respond to a verification request submitted by means other than a
				secure electronic database.</text>
								</subparagraph>
                <subparagraph id="id1c2885b9c2804acb871a07b1c9c066eb">
                  <enum>(E)</enum>
                  <header>Saleable
				returned product</header>
                  <text>Beginning 4 years after the date of enactment of
				the <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                    </short-title> (except as provided pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5" proposed="true">subsection (a)(5)</cato:entity-ref>), upon
				receipt of a returned product that the manufacturer intends to further
				distribute, before further distributing such product, the manufacturer shall
				verify the product identifier for each sealed homogeneous case of such product
				or, if such product is not in a sealed homogeneous case, verify the product
				identifier on each package.</text>
								</subparagraph>
                <subparagraph id="id0ADFF47B968D485088AB7ED1B907E8B5">
                  <enum>(F)</enum>
                  <header>Nonsaleable
				returned product</header>
                  <text>A manufacturer may return a nonsaleable product
				to the manufacturer or repackager, to the wholesale distributor from whom such
				product was purchased, or to a person acting on behalf of such a person,
				including a returns processor, without providing the information required under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:1/sp:A/cl:i" proposed="true">paragraph (1)(A)(i)</cato:entity-ref>.</text>
								</subparagraph>
              </paragraph>
            </subsection>
            <subsection id="id515e8624724141b3a829ef3727d673bc">
              <enum>(c)</enum>
              <header>Wholesale
				distributor requirements</header>
							<paragraph id="id43c44392ea4b442ba974a2c534ef6edd">
                <enum>(1)</enum>
                <header>Product
				tracing</header>
								<subparagraph id="iddec051a0ab3742b3af89477300dc20b4">
                  <enum>(A)</enum>
                  <header>In
				general</header>
                  <text>Beginning not later than 1 year after the date of
				enactment of the <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                    </short-title>, the following requirements shall apply to wholesale
				distributors:</text>
									<clause id="ida209f5a1826141bd9258aed1a349fa1d">
                    <enum>(i)</enum>
                    <text>A
				wholesale distributor shall not accept ownership of a product unless the
				previous owner prior to, or at the time of, the transaction provides the
				transaction history, transaction information, and a transaction statement for
				the product, as applicable under this subparagraph.</text>
									</clause>
                  <clause id="idec6c3f21f4ca4387b01700ab772537a6">
                    <enum>(ii)</enum>
                    <subclause commented="no" display-inline="yes-display-inline" id="idB1E29F596E504969BC8B59DEA5F0120D">
                      <enum>(I)</enum>
                      <item commented="no" display-inline="yes-display-inline" id="idA8678C37A34943248C98237F61AED7F6">
                        <enum>(aa)</enum>
                        <text>If the wholesale
				distributor purchased a product directly from the manufacturer, the exclusive
				distributor of the manufacturer, or a repackager that purchased directly from
				the manufacturer, then prior to, or at the time of, each transaction in which
				the wholesale distributor transfers ownership of a product, the wholesale
				distributor shall provide to the subsequent purchaser—</text>
												<subitem id="id144DA66C00EE42E58717A25048998D12" indent="up2">
                          <enum>(AA)</enum>
                          <text>a transaction statement, which shall
				state that such wholesale distributor, or a member of the affiliated group of
				such wholesale distributor, purchased the product directly from the
				manufacturer, exclusive distributor of the manufacturer, or repackager that
				purchased directly from the manufacturer; and</text>
												</subitem>
                        <subitem id="id65F2E50E265A45CFB606944619B29E19" indent="up2">
                          <enum>(BB)</enum>
                          <text>subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii/scl:II" proposed="true">subclause (II)</cato:entity-ref>, the
				transaction history and transaction information.</text>
												</subitem>
                      </item>
                      <item id="id7360D4E892B54DA1B697C75FC7E9BBEF" indent="up2">
                        <enum>(bb)</enum>
                        <text>The wholesale distributor shall provide
				the transaction history, transaction information, and transaction statement
				under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii/scl:I/i:aa" proposed="true">item (aa)</cato:entity-ref>—</text>
												<subitem id="idD64E034E0C534CAA8DEFA493037BE425">
                          <enum>(AA)</enum>
                          <text>if provided to a dispenser, on a
				single document in an electronic or paper format; and</text>
												</subitem>
                        <subitem id="id08F0F60688304FFFBB5A670F16CF10AA">
                          <enum>(BB)</enum>
                          <text>if provided to a wholesale
				distributor, through any combination of self-generated paper, electronic data,
				or manufacturer-provided information on the product package.</text>
												</subitem>
                      </item>
                    </subclause>
                    <subclause id="id639C6E5F42BF4976AEFDB972584953B3" indent="up1">
                      <enum>(II)</enum>
                      <text>For purposes of transactions described
				in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii/scl:I" proposed="true">subclause (I)</cato:entity-ref>, transaction history and transaction information shall not be
				required to include the lot number of the product, the initial transaction
				date, or the initial shipment date from the manufacturer (as defined in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:26/sp:F" proposed="true">subparagraphs (F)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:26/sp:G" proposed="true">(G)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:26/sp:H" proposed="true">(H) of section 581(26)</cato:entity-ref>).</text>
										</subclause>
                  </clause>
                  <clause id="id78906204a8674bb49c0c41d7c7f96d94">
                    <enum>(iii)</enum>
                    <text>If the
				wholesale distributor did not purchase a product directly from the
				manufacturer, the exclusive distributor of the manufacturer, or a repackager
				that purchased directly from the manufacturer, as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii" proposed="true">clause (ii)</cato:entity-ref>,
				then prior to, or at the time of, each transaction or subsequent transaction,
				the wholesale distributor—</text>
										<subclause id="idC658BE33CF6F440BB275E29B5926C515">
                      <enum>(I)</enum>
                      <text>shall provide to
				the subsequent purchaser a transaction statement, transaction history, and
				transaction information; and</text>
										</subclause>
                    <subclause id="idE111F29543C945D3909950940C01989E">
                      <enum>(II)</enum>
                      <text>may provide the
				information described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:iii/scl:I" proposed="true">subclause (I)</cato:entity-ref> to a subsequent purchaser on a single
				document in an electronic or paper format or through any combination of
				self-generated paper, electronic data, or manufacturer provided information on
				the product package.</text>
										</subclause>
                  </clause>
                  <clause id="idD8DF9EFF33E6440DA7B9BABF279D58F2">
                    <enum>(iv)</enum>
                    <text>For the purposes
				of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:iii/scl:I" proposed="true">clause (iii)(I)</cato:entity-ref>, the transaction history supplied shall begin only with the
				wholesale distributor described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii/scl:I" proposed="true">clause (ii)(I)</cato:entity-ref>, but the wholesale
				distributor described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:iii" proposed="true">clause (iii)</cato:entity-ref> shall inform the subsequent purchaser
				that such wholesale distributor received a direct purchase statement from the
				manufacturer, the exclusive distributor of the manufacturer, or a repackager
				that purchased directly from the manufacturer, and shall identify the
				manufacturer, exclusive distributor of the manufacturer, or repackager that
				purchased directly from the manufacturer from which the direct purchase
				statement was received.</text>
									</clause>
                  <clause id="id51717FED6206478590FEF87F9816ED11">
                    <enum>(v)</enum>
                    <text>A
				wholesale distributor shall maintain the transaction information, transaction
				history, and transaction statement for each transaction described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:i" proposed="true">clauses
				(i)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii" proposed="true">(ii)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:iii" proposed="true">(iii)</cato:entity-ref> for not less than 6 years after the date of the
				transaction.</text>
									</clause>
                </subparagraph>
                <subparagraph id="id132c7a783e6d4227ba458a2251e4d509">
                  <enum>(B)</enum>
                  <header>Returns</header>
									<clause id="id669faaa71d4f4613842062294613bdf2">
                    <enum>(i)</enum>
                    <header>Saleable
				returns</header>
                    <text>Notwithstanding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:i" proposed="true">subparagraph (A)(i)</cato:entity-ref>, the following shall
				apply:</text>
										<subclause id="id348999e394224b68ab28fb707a64da05">
                      <enum>(I)</enum>
                      <header>Requirements</header>
                      <text>Until
				the date that is 6 years after the date of enactment of the
				<short-title>
                          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                        </short-title>
				(except as provided pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5" proposed="true">subsection (a)(5)</cato:entity-ref>), a wholesale distributor may
				accept returned product from a dispenser pursuant to the terms and conditions
				of any agreement between the parties, and, notwithstanding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii" proposed="true">subparagraph
				(A)(ii)</cato:entity-ref>, may distribute such returned product without providing the transaction
				history. For transactions subsequent to the return, the transaction history of
				such product shall begin with the wholesale distributor that accepted the
				returned product, consistent with the requirements of this subsection.</text>
										</subclause>
                    <subclause id="id96dc345e92be455da7a8704f6b5bb3f5">
                      <enum>(II)</enum>
                      <header>Enhanced
				requirements</header>
                      <text>Beginning 6 years after the date of enactment of the
				<short-title>
                          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                        </short-title>
				(except as provided pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5" proposed="true">subsection (a)(5)</cato:entity-ref>), a wholesale distributor may
				accept returned product from a dispenser only if the wholesale distributor can
				associate returned product with the transaction information and transaction
				statement associated with that product. For all transactions after such date,
				the transaction history, as applicable, of such product shall begin with the
				wholesale distributor that accepted and verified the returned product. For
				purposes of this subparagraph, the transaction information and transaction
				history, as applicable, need not include transaction dates if it is not
				reasonably practicable to obtain such dates.</text>
										</subclause>
                  </clause>
                  <clause id="id69d05d5e8da443feae2276d6c5df9beb">
                    <enum>(ii)</enum>
                    <header>Nonsaleable
				returns</header>
                    <text>A wholesale distributor may return a nonsaleable
				prescription drug to the manufacturer or repackager, to the wholesale
				distributor from whom such prescription drug was purchased, or to a person
				acting on behalf of such a person, including a returns processor, without
				providing the information required under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:i" proposed="true">subparagraph (A)(i)</cato:entity-ref>.</text>
									</clause>
                </subparagraph>
                <subparagraph id="idbe801327dfd54f958da4d668f45aa0d2">
                  <enum>(C)</enum>
                  <header>Requests for
				information</header>
                  <text>Upon a request by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or other appropriate
				Federal or State official, in the event of a recall or for the purpose of
				investigating a suspect product or an illegitimate product a wholesale
				distributor shall, not later than 24 hours after receiving the request or in
				other such reasonable time as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, based on the
				circumstances of the request, provide the applicable transaction information,
				transaction history, and transaction statement for the product.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="iddc2b9ec5d1ff4e53ad6a111a41154633">
                <enum>(2)</enum>
                <header>Product
				identifier</header>
                <text>Beginning 6 years after the date of enactment of the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                  </short-title>,
				a wholesale distributor may engage in transactions involving a product only if
				such product is encoded with a product identifier (except as provided pursuant
				to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5" proposed="true">subsection (a)(5)</cato:entity-ref>).</text>
							</paragraph>
              <paragraph id="id1ded1eddae5b4119ac1981427f023678">
                <enum>(3)</enum>
                <header>Authorized
				trading partners</header>
                <text>Beginning not later than 1 year after the date
				of enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain
				Security Act</cato:entity-ref>
                  </short-title>, the trading partners of a wholesale distributor may
				be only authorized trading partners.</text>
							</paragraph>
              <paragraph id="id15f43b513bdd4a52a0382293ee8a06be">
                <enum>(4)</enum>
                <header>Verification</header>
                <text>Beginning
				not later than 1 year after the date of enactment of the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                  </short-title>,
				a wholesale distributor shall have systems in place to enable the wholesale
				distributor to comply with the following requirements:</text>
								<subparagraph id="idebd2595aacfb4b25b96ae8941449ac29">
                  <enum>(A)</enum>
                  <header>Suspect
				product</header>
									<clause id="id2235aa7f6a2e48948c9b52d21dad0825">
                    <enum>(i)</enum>
                    <header>In
				general</header>
                    <text>Upon making a determination that a product in the
				possession or control of the wholesale distributor is a suspect product, or
				upon receiving a request for verification from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> that has made a
				determination that a product within the possession or control of a wholesale
				distributor is a suspect product, a wholesale distributor shall—</text>
										<subclause id="idfce32860949b4ce59d36fd270c0f9f34">
                      <enum>(I)</enum>
                      <text>quarantine such
				product within the possession or control of the wholesale distributor from
				product intended for distribution until such product is cleared or
				dispositioned; and</text>
										</subclause>
                    <subclause id="id9573d2f936214817bdddc9fd16c6c64d">
                      <enum>(II)</enum>
                      <text>promptly conduct
				an investigation in coordination with trading partners, as applicable, to
				determine whether the product is an illegitimate product, which shall include
				validating any applicable transaction history and transaction information in
				the possession of the wholesale distributor and otherwise investigating to
				determine whether the product is an illegitimate product, and, beginning 6
				years after the date of enactment of the <short-title>
                          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug
				Supply Chain Security Act</cato:entity-ref>
                        </short-title> (except as provided pursuant to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5" proposed="true">subsection (a)(5)</cato:entity-ref>), verifying the product at the package level.</text>
										</subclause>
                  </clause>
                  <clause id="idaf0676b070f94ccf9a3fd176851ec1be">
                    <enum>(ii)</enum>
                    <header>Cleared
				product</header>
                    <text>If the wholesale distributor determines that a suspect
				product is not an illegitimate product, the wholesale distributor shall
				promptly notify the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, if applicable, of such determination and such
				product may be further distributed.</text>
									</clause>
                  <clause id="id3658897282b6454c9fbd90fc472d85e4">
                    <enum>(iii)</enum>
                    <header>Records</header>
                    <text>A
				wholesale distributor shall keep records of the investigation of a suspect
				product for not less than 6 years after the conclusion of the
				investigation.</text>
									</clause>
                </subparagraph>
                <subparagraph id="id67df907e0b834a04859800ce55488aa8">
                  <enum>(B)</enum>
                  <header>Illegitimate
				product</header>
									<clause id="id64a1cf8458514a6786ff0fef01735c18">
                    <enum>(i)</enum>
                    <header>In
				general</header>
                    <text>Upon determining, in coordination with the manufacturer,
				that a product in the possession or control of a wholesale distributor is an
				illegitimate product, the wholesale distributor shall, in a manner that is
				consistent with the systems and processes of such wholesale distributor—</text>
										<subclause id="ida3aa78caf8174688afeb6f93c663c48d">
                      <enum>(I)</enum>
                      <text>quarantine such
				product within the possession or control of the wholesale distributor from
				product intended for distribution until such product is dispositioned;</text>
										</subclause>
                    <subclause id="idde02722ffc2d4c08a4e52519d4569c63">
                      <enum>(II)</enum>
                      <text>disposition the
				illegitimate product within the possession or control of the wholesale
				distributor;</text>
										</subclause>
                    <subclause id="idf44cad8df77b4e6f884252b96149cf4b">
                      <enum>(III)</enum>
                      <text>take reasonable
				and appropriate steps to assist a trading partner to disposition an
				illegitimate product not in the possession or control of the wholesale
				distributor; and</text>
										</subclause>
                    <subclause id="id763C99D2FF5A4FC698A09CE63901D343">
                      <enum>(IV)</enum>
                      <text>retain a sample
				of the product for further physical examination or laboratory analysis of the
				product by the manufacturer or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> (or other appropriate Federal or State
				official) upon request by the manufacturer or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> (or other appropriate
				Federal or State official), as necessary and appropriate.</text>
										</subclause>
                  </clause>
                  <clause id="iddad1db1fc75e457aaca41dc6398879a0">
                    <enum>(ii)</enum>
                    <header>Making a
				notification</header>
                    <text>Upon determining that a product in the possession or
				control of the wholesale distributor is an illegitimate product, the wholesale
				distributor shall notify the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and all immediate trading partners that
				the wholesale distributor has reason to believe may have received such
				illegitimate product of such determination not later than 24 hours after making
				such determination.</text>
									</clause>
                  <clause id="id6ac7aef27c3041988054b5e5408c8e7c">
                    <enum>(iii)</enum>
                    <header>Responding to
				a notification</header>
                    <text>Upon the receipt of a notification from the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or a trading partner that a determination has been made that a
				product is an illegitimate product, a wholesale distributor shall identify all
				illegitimate product subject to such notification that is in the possession or
				control of the wholesale distributor, including any product that is
				subsequently received, and shall perform the activities described in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:4/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>.</text>
									</clause>
                  <clause id="id5F1AED23A637482D9A01FB2590AD01ED">
                    <enum>(iv)</enum>
                    <header>Terminating a
				notification</header>
                    <text>Upon a determination, in consultation with the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, that a notification is no longer necessary, a wholesale distributor
				shall promptly notify immediate trading partners that the wholesale distributor
				notified pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:4/sp:B/cl:ii" proposed="true">clause (ii)</cato:entity-ref> that such notification has been
				terminated.</text>
									</clause>
                  <clause id="idd3b792bae90d4f928a6e47ac62e9e626">
                    <enum>(v)</enum>
                    <header>Records</header>
                    <text>A
				wholesale distributor shall keep records of the disposition of an illegitimate
				product for not less than 6 years after the conclusion of the
				disposition.</text>
									</clause>
                </subparagraph>
                <subparagraph id="id6e71015b977f4af0b3bee4637a6b317d">
                  <enum>(C)</enum>
                  <header>Electronic
				database</header>
                  <text>A wholesale distributor may satisfy the requirements of
				this paragraph by developing a secure electronic database or utilizing a secure
				electronic database developed or operated by another entity. The owner of such
				database shall establish the requirements and processes to respond to requests
				and may provide for data access to other members of the pharmaceutical
				distribution supply chain, as appropriate. The development and operation of
				such a database shall not relieve a wholesale distributor of the requirement
				under this paragraph to respond to a verification request submitted by means
				other than a secure electronic database.</text>
								</subparagraph>
                <subparagraph id="idcd9421d35fcb43f8b08e8a07052627dd">
                  <enum>(D)</enum>
                  <header>Verification of
				saleable returned product</header>
                  <text>Beginning 6 years after the date of
				enactment of the <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                    </short-title>, upon receipt of a returned product that the wholesale
				distributor intends to further distribute, before further distributing such
				product, the wholesale distributor shall verify the product identifier for each
				sealed homogeneous case of such product or, if such product is not in a sealed
				homogeneous case, verify the product identifier on each package.</text>
								</subparagraph>
              </paragraph>
            </subsection>
            <subsection id="ida57260e705a744548a196a6d29561ac7">
              <enum>(d)</enum>
              <header>Dispenser
				requirements</header>
							<paragraph id="id73543783008a4d09a69e44fec590d07b">
                <enum>(1)</enum>
                <header>Product
				tracing</header>
								<subparagraph id="id327026c77d7e40caa7a3eed97c1c132b">
                  <enum>(A)</enum>
                  <header>In
				general</header>
                  <text>Beginning 1 year after the date of enactment of the
				<short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                    </short-title>,
				a dispenser—</text>
									<clause id="id1ccba8b3b5de4cc2a910252fd58b248f">
                    <enum>(i)</enum>
                    <text>shall not accept
				ownership of a product, unless the previous owner prior to, or at the time of,
				the transaction, provides transaction history, transaction information, and a
				transaction statement;</text>
									</clause>
                  <clause id="id2539a94040ca4446a49d19f18daaea37">
                    <enum>(ii)</enum>
                    <text>prior to, or at
				the time of, each transaction in which the dispenser transfers ownership of a
				product (but not including dispensing to a patient or returns) shall provide
				the subsequent owner with transaction history, transaction information, and a
				transaction statement for the product, except that the requirements of this
				clause shall not apply to sales by a dispenser to another dispenser to fulfill
				a specific patient need; and</text>
									</clause>
                  <clause id="idc6cea9bc94114ba5b955506261430749">
                    <enum>(iii)</enum>
                    <text>shall maintain
				transaction information, transaction history, and transaction statements, as
				necessary to investigate a suspect product, for not less than 6 years after the
				transaction.</text>
									</clause>
                </subparagraph>
                <subparagraph id="ida801182fdf8f414882033510b30ec31f">
                  <enum>(B)</enum>
                  <header>Agreements with
				third parties</header>
                  <text>A dispenser may enter into a written agreement with
				a third party, including an authorized wholesale distributor, under which the
				third party confidentially maintains the transaction information, transaction
				history, and transaction statements required to be maintained under this
				subsection on behalf of the dispenser. If a dispenser enters into such an
				agreement, the dispenser shall maintain a copy of the written agreement and
				shall not be relieved of the obligations of the dispenser under this
				subsection.</text>
								</subparagraph>
                <subparagraph id="idddbcd6d87a6642a3bf24e3ce912f5ce7">
                  <enum>(C)</enum>
                  <header>Returns</header>
									<clause id="idaedba11005a24e8c8980d14160413784">
                    <enum>(i)</enum>
                    <header>Saleable
				returns</header>
                    <text>A dispenser may return product to the trading partner
				from which the dispenser obtained the product without providing the information
				required under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:1/sp:B" proposed="true">subparagraph (B)</cato:entity-ref>.</text>
									</clause>
                  <clause id="idfb0aa4e9e7174adb80d895e636d12532">
                    <enum>(ii)</enum>
                    <header>Nonsaleable
				returns</header>
                    <text>A dispenser may return a nonsaleable product to the
				manufacturer or repackager, to the wholesale distributor from whom such product
				was purchased, to a returns processor, or to a person acting on behalf of such
				persons without providing the information required under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:1/sp:A/cl:i" proposed="true">subparagraph
				(A)(i)</cato:entity-ref>.</text>
									</clause>
                </subparagraph>
                <subparagraph id="id678c802e3067489b8b5598989d57bbe3">
                  <enum>(D)</enum>
                  <header>Requests for
				information</header>
                  <text>Upon a request by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or other appropriate
				Federal or State official, in the event of a recall or for the purpose of
				investigating a suspect or an illegitimate product, a dispenser shall, not
				later than 2 business days after receiving the request or in another such
				reasonable time as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, based on the circumstances of
				the request, provide the applicable transaction information, transaction
				statement, and transaction history which the dispenser received from the
				previous owner, which shall not include the lot number of the product, the
				initial transaction date, or the initial shipment date from the manufacturer
				unless such information was included in the transaction information,
				transaction statement, and transaction history provided by the manufacturer or
				wholesale distributor to the dispenser.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="id938da59b96a14b9e811d205b3244aaaa">
                <enum>(2)</enum>
                <header>Product
				identifier</header>
                <text>Beginning not later than 7 years after the date of
				enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>, a dispenser may engage in transactions involving a product
				only if such product is encoded with a product identifier (except as provided
				pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5" proposed="true">subsection (a)(5)</cato:entity-ref>).</text>
							</paragraph>
              <paragraph id="id2ad3a5f0820c4d3c9755cac5a12e3bb3">
                <enum>(3)</enum>
                <header>Authorized
				trading partners</header>
                <text>Beginning not later than 1 year after the date
				of enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain
				Security Act</cato:entity-ref>
                  </short-title>, the trading partners of a dispenser may be only
				authorized trading partners.</text>
							</paragraph>
              <paragraph id="id852cd707db164252b4f3c44ac483604c">
                <enum>(4)</enum>
                <header>Verification</header>
                <text>Beginning
				not later than 1 year after the date of enactment of the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                  </short-title>,
				a dispenser shall have systems in place to enable the dispenser to comply with
				the following requirements:</text>
								<subparagraph id="id32e298f707e24001997103b5c7105c38">
                  <enum>(A)</enum>
                  <header>Suspect
				product</header>
									<clause id="idd429fb01992d4d5db52116dcbc4a67d9">
                    <enum>(i)</enum>
                    <header>In
				general</header>
                    <text>Upon making a determination that a product in the
				possession or control of the dispenser is a suspect product, or upon receiving
				a request for verification from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> that has made a determination
				that a product within the possession or control of a dispenser is a suspect
				product, a dispenser shall—</text>
										<subclause id="idb042373d629d402e94501e5efdc3606d">
                      <enum>(I)</enum>
                      <text>quarantine such
				product within the possession or control of the dispenser from product intended
				for distribution until such product is cleared or dispositioned; and</text>
										</subclause>
                    <subclause id="iddb65ce0d80a54810b519bf785709a317">
                      <enum>(II)</enum>
                      <text>promptly conduct
				an investigation in coordination with trading partners, as applicable, to
				determine whether the product is an illegitimate product.</text>
										</subclause>
                  </clause>
                  <clause id="id132C92A4C06444C489593AABDCD99625">
                    <enum>(ii)</enum>
                    <header>Investigation</header>
                    <text>An
				investigation conducted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:4/sp:A/cl:i/scl:II" proposed="true">clause (i)(II)</cato:entity-ref> shall include—</text>
										<subclause id="idfd2c2c0dc94d48eab41d9f7d0cdb9b29">
                      <enum>(I)</enum>
                      <text>beginning 7 years
				after the date of enactment of the <short-title>
                          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug
				Supply Chain Security Act</cato:entity-ref>
                        </short-title>, verifying whether the lot number of a
				suspect product corresponds with the lot number for such product;</text>
										</subclause>
                    <subclause id="id3fee2eeb998544e78e4fee520534ccfc">
                      <enum>(II)</enum>
                      <text>beginning 7
				years after the date of enactment of such Act, verifying that the product
				identifier of at least 3 packages or 10 percent of such suspect product,
				whichever is greater, or all packages, if there are fewer than 3, corresponds
				with the product identifier for such product;</text>
										</subclause>
                    <subclause id="id84fa568e382e4b5494ae3c7712042eac">
                      <enum>(III)</enum>
                      <text>validating any
				applicable transaction history and transaction information in the possession of
				the dispenser; and</text>
										</subclause>
                    <subclause id="idb00129d26377473494a394182aea23c2">
                      <enum>(IV)</enum>
                      <text>otherwise
				investigating to determine whether the product is an illegitimate
				product.</text>
										</subclause>
                  </clause>
                  <clause id="id6b15e40f5f534f709156ad42621eb3c7">
                    <enum>(iii)</enum>
                    <header>Cleared
				product</header>
                    <text>If the dispenser makes the determination that a suspect
				product is not an illegitimate product, the dispenser shall promptly notify the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, if applicable, of such determination and such product may be further
				distributed or dispensed.</text>
									</clause>
                  <clause id="idf09176bdaad94a948e90192fad79060f">
                    <enum>(iv)</enum>
                    <header>Records</header>
                    <text>A
				dispenser shall keep records of the investigation of a suspect product for not
				less than 6 years after the conclusion of the investigation.</text>
									</clause>
                </subparagraph>
                <subparagraph id="id68643f492d834cf49d0c289a88f8326c">
                  <enum>(B)</enum>
                  <header>Illegitimate
				product</header>
									<clause id="id1b5fcd8a4ed040de86153a2492e5bea3">
                    <enum>(i)</enum>
                    <header>In
				general</header>
                    <text>Upon determining, in coordination with the manufacturer,
				that a product in the possession or control of a dispenser is an illegitimate
				product, the dispenser shall—</text>
										<subclause id="idf118465e15de4f3a87ea1b4bb31e6f20">
                      <enum>(I)</enum>
                      <text>disposition the
				illegitimate product within the possession or control of the dispenser;</text>
										</subclause>
                    <subclause id="ide4d26696fca840ffb513d61e8e48999e">
                      <enum>(II)</enum>
                      <text>take reasonable
				and appropriate steps to assist a trading partner to disposition an
				illegitimate product not in the possession or control of the dispenser;
				and</text>
										</subclause>
                    <subclause id="idD83E49DA7F9C4DF38593D9EA6F61114C">
                      <enum>(III)</enum>
                      <text>retain a sample
				of the product for further physical examination or laboratory analysis of the
				product by the manufacturer or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> (or other appropriate Federal or State
				official) upon request by the manufacturer or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> (or other appropriate
				Federal or State official), as necessary and appropriate.</text>
										</subclause>
                  </clause>
                  <clause id="id68a7b2ac302a41a3bbda0b9c7c0dec85">
                    <enum>(ii)</enum>
                    <header>Making a
				notification</header>
                    <text>Upon determining that a product in the possession or
				control of the dispenser is an illegitimate product, the dispenser shall notify
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and all immediate trading partners that the dispenser has reason
				to believe may have received such illegitimate product of such determination
				not later than 24 hours after making such determination.</text>
									</clause>
                  <clause id="iddab89879fd6f43dda911d1b03502654c">
                    <enum>(iii)</enum>
                    <header>Responding to
				a notification</header>
                    <text>Upon the receipt of a notification from the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or a trading partner that a determination has been made that a
				product is an illegitimate product, a dispenser shall identify all illegitimate
				product subject to such notification that is in the possession or control of
				the dispenser, including any product that is subsequently received, and shall
				perform the activities described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:4/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>.</text>
									</clause>
                  <clause id="id37792e7da08340a0880ab74e4063d70e">
                    <enum>(iv)</enum>
                    <header>Terminating a
				notification</header>
                    <text>Upon making a determination, in consultation with
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, that a notification is no longer necessary, a dispenser shall
				promptly notify immediate trading partners that the dispenser notified pursuant
				to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:4/sp:B/cl:ii" proposed="true">clause (ii)</cato:entity-ref> that such notification has been terminated.</text>
									</clause>
                  <clause id="idAEB7D96C7A614D6EB6BEA54D9F44BE60">
                    <enum>(v)</enum>
                    <header>Records</header>
                    <text>A
				dispenser shall keep records of the disposition of an illegitimate product for
				not less than 6 years after the conclusion of the disposition.</text>
									</clause>
                </subparagraph>
                <subparagraph id="idd3799f408f6c477688c62adc19fd2bbf">
                  <enum>(C)</enum>
                  <header>Electronic
				database</header>
                  <text>A dispenser may satisfy the requirements of this
				paragraph by developing a secure electronic database or utilizing a secure
				electronic database developed or operated by another entity.</text>
								</subparagraph>
              </paragraph>
            </subsection>
            <subsection id="id3d0d4b915f48401f8a0d31bee2ebdf84">
              <enum>(e)</enum>
              <header>Repackager
				requirements</header>
							<paragraph id="id763126f5ed6f41a0ba0ba536ba084bef">
                <enum>(1)</enum>
                <header>Product
				tracing</header>
								<subparagraph id="idbae7a878bab649929a4eed9833e738d6">
                  <enum>(A)</enum>
                  <header>In
				general</header>
                  <text>Beginning not later than 1 year after the date of
				enactment of the <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                    </short-title>, a repackager shall—</text>
									<clause id="ida26c87e5c5fd480ebd2aecc13f5fe88f">
                    <enum>(i)</enum>
                    <text>not accept
				ownership of a product unless the previous owner, prior to, or at the time of,
				the transaction, provides transaction history, transaction information, and a
				transaction statement for the product;</text>
									</clause>
                  <clause id="id59261e54eac2429ebd5909e58b8672ad">
                    <enum>(ii)</enum>
                    <text>prior to, or at
				the time of, each transaction in which the repackager transfers ownership of a
				product, or transfers possession of a product to a third-party logistics
				provider, provide the subsequent owner with transaction history, transaction
				information, and a transaction statement; and</text>
									</clause>
                  <clause id="idaf3774e04e1347a7bfaa1cc92d82e91e">
                    <enum>(iii)</enum>
                    <text>maintain the
				transaction information, transaction history, and transaction statement for
				each transaction described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:1/sp:A/cl:i" proposed="true">clauses (i)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:1/sp:A/cl:ii" proposed="true">(ii)</cato:entity-ref> for not less than 6 years
				after the transaction.</text>
									</clause>
                </subparagraph>
                <subparagraph id="idfaeddf0a81b84c81a726fa6eecd231bb">
                  <enum>(B)</enum>
                  <header>Nonsaleable
				returns</header>
                  <text>A repackager may return a nonsaleable product to the
				manufacturer or repackager, or to the wholesale distributor from whom such
				product was purchased, or to a person acting on behalf of such a person,
				including a returns processor, without providing the information required under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:1/sp:A/cl:ii" proposed="true">subparagraph (A)(ii)</cato:entity-ref>.</text>
								</subparagraph>
                <subparagraph id="idb20f9d692bea4927b8f634d1c3b79de6">
                  <enum>(C)</enum>
                  <header>Requests for
				information</header>
                  <text>Upon a request by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or other appropriate
				Federal or State official, in the event of a recall or for the purpose of
				investigating a suspect product or an illegitimate product, a repackager shall,
				not later than 24 hours after receiving the request or in other such reasonable
				time as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, based on the circumstances of the request,
				provide the applicable transaction information, transaction history and
				transaction statement for the product.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="idba23fc623f2149a690645ac22e9dfced">
                <enum>(2)</enum>
                <header>Product
				identifier</header>
                <text>Beginning not later than 5 years after enactment of
				the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>, a repackager—</text>
								<subparagraph id="id6817cfe581244e73966464b8c4c567fa">
                  <enum>(A)</enum>
                  <text>shall a fix or
				imprint a product identifier to each package and homogenous case of product
				intended to be introduced in a transaction in commerce;</text>
								</subparagraph>
                <subparagraph id="id8042B3A76DCF47138390E8E86B60CCD0">
                  <enum>(B)</enum>
                  <text>shall maintain
				the product identifier information for such product for not less than 6 years
				after the date of the transaction;</text>
								</subparagraph>
                <subparagraph id="idf668b681ea954b6fb4aadca632f65dca">
                  <enum>(C)</enum>
                  <text>may engage in
				transactions involving a product only if such product is encoded with a product
				identifier (except as provided pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5" proposed="true">subsection (a)(5)</cato:entity-ref>); and</text>
								</subparagraph>
                <subparagraph id="iddacde1bfa5ab4a868c13e663441e8c6d">
                  <enum>(D)</enum>
                  <text>maintain records
				for not less than 6 years to allow the repackager to associate the product
				identifier the repackager affixes or imprints with the product identifier
				assigned by the original manufacturer of the product.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="id8b108646ae574d5faba5091ab3dcee5f">
                <enum>(3)</enum>
                <header>Authorized
				trading partners</header>
                <text>Beginning 1 year after the date of enactment of
				the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>, the trading partners of a repackager may be only authorized
				trading partners.</text>
							</paragraph>
              <paragraph id="idf96a8e24df5d49ee8a6c2df44c9e65c7">
                <enum>(4)</enum>
                <header>Verification</header>
                <text>Beginning
				not later than 1 year after the date of enactment of the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                  </short-title>,
				a repackager shall have systems in place to enable the repackager to comply
				with the following requirements:</text>
								<subparagraph id="idab7a652119ae44c3b9cd29312461f772">
                  <enum>(A)</enum>
                  <header>Suspect
				product</header>
									<clause id="id0a232a49484c430c86bdf27f55c919ef">
                    <enum>(i)</enum>
                    <header>In
				general</header>
                    <text>Upon making a determination that a product in the
				possession or control of the repackager is a suspect product, or upon receiving
				a request for verification from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> that has made a determination
				that a product within the possession or control of a repackager is a suspect
				product, a repackager shall—</text>
										<subclause id="id02d1196d2174420d9aefee00b499c025">
                      <enum>(I)</enum>
                      <text>quarantine such
				product within the possession or control of the repackager from product
				intended for distribution until such product is cleared or dispositioned;
				and</text>
										</subclause>
                    <subclause id="id69bb8fa2cd424e27b49478878043fe38">
                      <enum>(II)</enum>
                      <text>promptly conduct
				an investigation in coordination with trading partners, as applicable, to
				determine whether the product is an illegitimate product, which shall include
				validating any applicable transaction history and transaction information in
				the possession of the repackager and otherwise investigating to determine
				whether the product is an illegitimate product, and, beginning 5 years after
				the date of enactment of the <short-title>
                          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply
				Chain Security Act</cato:entity-ref>
                        </short-title> (except as provided pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5" proposed="true">subsection
				(a)(5)</cato:entity-ref>), verifying the product at the package level.</text>
										</subclause>
                  </clause>
                  <clause id="id2db72b73c07542df99cb486c06411687">
                    <enum>(ii)</enum>
                    <header>Cleared
				product</header>
                    <text>If the repackager makes the determination that a suspect
				product is not an illegitimate product, the repackager shall promptly notify
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, if applicable, of such determination and such product may be
				further distributed.</text>
									</clause>
                  <clause id="id9e23bbf0d5ef46978c3c479f2514aece">
                    <enum>(iii)</enum>
                    <header>Records</header>
                    <text>A
				repackager shall keep records of the investigation of a suspect product for not
				less than 6 years after the conclusion of the investigation.</text>
									</clause>
                </subparagraph>
                <subparagraph id="id3f8fb743710d43b9a161bff3994a6b73">
                  <enum>(B)</enum>
                  <header>Illegitimate
				product</header>
									<clause id="id41878dc0ded34ca5988cafac6bafcff1">
                    <enum>(i)</enum>
                    <header>In
				general</header>
                    <text>Upon determining, in coordination with the manufacturer,
				that a product in the possession or control of a repackager is an illegitimate
				product, the repackager shall, in a manner that is consistent with the systems
				and processes of such repackager—</text>
										<subclause id="id6050a2cfcfde471b960373cc6300e22b">
                      <enum>(I)</enum>
                      <text>quarantine such
				product within the possession or control of the repackager from product
				intended for distribution until such product is dispositioned;</text>
										</subclause>
                    <subclause id="id1D54FDA248A74DB7A7789ECF7F44B600">
                      <enum>(II)</enum>
                      <text>disposition the
				illegitimate product within the possession or control of the repackager;</text>
										</subclause>
                    <subclause id="id730f085fe8764cb99a2817a85c0a90a4">
                      <enum>(III)</enum>
                      <text>take reasonable
				and appropriate steps to assist a trading partner to disposition an
				illegitimate product not in the possession or control of the repackager;
				and</text>
										</subclause>
                    <subclause id="id9C628FE8E956491384CA6D293B00AECE">
                      <enum>(IV)</enum>
                      <text>retain a sample
				of the product for further physical examination or laboratory analysis of the
				product by the manufacturer or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> (or other appropriate Federal or State
				official) upon request by the manufacturer or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> (or other appropriate
				Federal or State official), as necessary and appropriate.</text>
										</subclause>
                  </clause>
                  <clause id="id28d794a2dcf444ada3395d992d614a0d">
                    <enum>(ii)</enum>
                    <header>Making a
				notification</header>
                    <text>Upon determining that a product in the possession or
				control of the repackager is an illegitimate product, the repackager shall
				notify the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and all immediate trading partners that the repackager has
				reason to believe may have received the illegitimate product of such
				determination not later than 24 hours after making such determination.</text>
									</clause>
                  <clause id="id760720e2df0c4bc89adff1b862da8cf2">
                    <enum>(iii)</enum>
                    <header>Responding to
				a notification</header>
                    <text>Upon the receipt of a notification from the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or a trading partner, a repackager shall identify all illegitimate
				product subject to such notification that is in the possession or control of
				the repackager, including any product that is subsequently received, and shall
				perform the activities described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>.</text>
									</clause>
                  <clause id="ida599d7364a4e4327b33d51324e2a9042">
                    <enum>(iv)</enum>
                    <header>Terminating a
				notification</header>
                    <text>Upon a determination, in consultation with the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, that a notification is no longer necessary, a repackager shall
				promptly notify immediate trading partners that the repackager notified
				pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4/sp:B/cl:ii" proposed="true">clause (ii)</cato:entity-ref> that such notification has been terminated.</text>
									</clause>
                  <clause id="id806B72414F144A4CAD04BF3F71EB9975">
                    <enum>(v)</enum>
                    <header>Records</header>
                    <text>A
				repackager shall keep records of the disposition of an illegitimate product for
				not less than 6 years after the conclusion of the disposition.</text>
									</clause>
                </subparagraph>
                <subparagraph id="ide4820ac802f64985838c89e206211e68">
                  <enum>(C)</enum>
                  <header>Requests for
				verification</header>
                  <text>Beginning 5 years after enactment of the
				<short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                    </short-title>,
				upon receiving a request for verification from an authorized manufacturer,
				wholesale distributor, or dispenser that is in possession or control of a
				product they believe to be repackaged by such repackager, a repackager shall,
				not later than 24 hours after receiving the verification request or in other
				such reasonable time as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, based on the circumstances
				of the request, notify the person making the request whether the product
				identifier, including the standard numeric identifier, that is the subject of
				the request corresponds to the product identifier affixed or imprinted by the
				repackager. If a repackager responding to a verification request identifies a
				product identifier that does not correspond to that affixed or imprinted by the
				repackager, the repackager shall treat such product as suspect product and
				conduct an investigation as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>. If the repackager
				has reason to believe the product is an illegitimate product, the repackager
				shall advise the person making the request of such belief at the time such
				manufacturer responds to the verification request.</text>
								</subparagraph>
                <subparagraph id="idf0150b18226146198a59f5de1e43517e">
                  <enum>(D)</enum>
                  <header>Electronic
				database</header>
                  <text>A repackager may satisfy the requirements of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4" proposed="true">paragraph
				(4)</cato:entity-ref> by developing a secure electronic database or utilizing a secure electronic
				database developed or operated by another entity. The owner of such database
				shall establish the requirements and processes to respond to requests and may
				provide for data access to other members of the pharmaceutical distribution
				supply chain, as appropriate. The development and operation of such a database
				shall not relieve a repackager of the requirement under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4" proposed="true">paragraph (4)</cato:entity-ref> to
				respond to a verification request submitted by means other than a secure
				electronic database.</text>
								</subparagraph>
                <subparagraph id="id4234272c8c554b15ae1ac2d830bdcc11">
                  <enum>(E)</enum>
                  <header>Verification of
				saleable returned product</header>
                  <text>Beginning 5 years after the date of
				enactment of the <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                    </short-title>, upon receipt of a returned product that the repackager
				intends to further distribute, before further distributing such product, the
				repackager shall verify the product identifier for each sealed homogeneous case
				of such product or, if such product is not in a sealed homogeneous case, verify
				the product identifier on each package.</text>
								</subparagraph>
              </paragraph>
            </subsection>
            <subsection id="id0c227a1b27574be8ac8411e9f2ea9694">
              <enum>(f)</enum>
              <header>Third-Party
				logistics provider requirements</header>
							<paragraph commented="no" id="id27e979a8240045358ab1c2bd684a9be3">
                <enum>(1)</enum>
                <header>In
				general</header>
                <text>Beginning not later than 1 year after the date of
				enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>, a third-party logistics provider shall—</text>
								<subparagraph id="id1ec32f7931294f85a97669b7dafd19d1">
                  <enum>(A)</enum>
                  <text>not accept
				possession of a product unless the owner of the product provides the
				transaction history, transaction information, and a transaction statement for
				the product;</text>
								</subparagraph>
                <subparagraph id="ida1cc5d39a7404fbab6e9bccff3b5e904">
                  <enum>(B)</enum>
                  <text>maintain a copy
				of the information described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:1/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> for not less than 6 years
				after the transfer of possession; and</text>
								</subparagraph>
                <subparagraph id="id12C59C70851E4852BDBF4552103F67BB">
                  <enum>(C)</enum>
                  <text>upon a request by
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or other appropriate Federal or State official, in the event of a
				recall or for the purpose of investigating a suspect product or an illegitimate
				product, not later than 24 hours after receiving the request or in other such
				reasonable time as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> based on the circumstances of
				the request, provide the applicable transaction information, transaction
				history, and transaction statement for the product.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="id0c8d363eb35c40d68b29f43ef76ef060">
                <enum>(2)</enum>
                <header>Product
				tracing</header>
                <text>Beginning not later than 6 years after the date of
				enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>, a third-party logistics provider may accept possession of
				product only if such product is encoded with a product identifier (except as
				provided pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5" proposed="true">subsection (a)(5)</cato:entity-ref>).</text>
							</paragraph>
              <paragraph id="id1f6080e38c444bbc9af385f4f0e7f9aa">
                <enum>(3)</enum>
                <header>Authorized
				trading partners</header>
                <text>Beginning 1 year after the date of enactment of
				the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>, the trading partners of a third-party logistics provider may
				be only authorized trading partners.</text>
							</paragraph>
              <paragraph id="idc80806f9a88e49e5a361ee8378bc2931">
                <enum>(4)</enum>
                <header>Verification</header>
                <text>Beginning
				not later than 1 year after the date of enactment of the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                  </short-title>,
				a third-party logistics provider shall have systems in place to enable the
				third-party logistics provider to comply with the following
				requirements:</text>
								<subparagraph id="idf62ceacbfa7e44a5814990b6c8e5feb0">
                  <enum>(A)</enum>
                  <header>Suspect
				product</header>
									<clause id="id3603b838fee940e1a9edce77dee7a828">
                    <enum>(i)</enum>
                    <header>In
				general</header>
                    <text>Upon making a determination that a product in the
				possession or control of a third-party logistics provider is a suspect product,
				a third-party logistics provider shall—</text>
										<subclause id="idebb64ace18cc433e8d70ae721022fd74">
                      <enum>(I)</enum>
                      <text>quarantine such
				product within the possession or control of the third-party logistics provider
				from product intended for distribution until such product is cleared or
				transferred to the owner of such product for disposition of the product;
				and</text>
										</subclause>
                    <subclause id="idf15fdf29328640b7bf283380c829de75">
                      <enum>(II)</enum>
                      <text>promptly notify
				the owner of such product of the need to conduct an investigation to determine
				whether the product is an illegitimate product.</text>
										</subclause>
                  </clause>
                  <clause id="id13d87833b00f43cd96a684cfe98653ff">
                    <enum>(ii)</enum>
                    <header>Cleared
				product</header>
                    <text>If the owner of the product notifies the third-party
				logistics provider of the determination that a suspect product is not an
				illegitimate product, such product may be further distributed.</text>
									</clause>
                  <clause id="idab3bc8c1548448f39a99df3c8a144d90">
                    <enum>(iii)</enum>
                    <header>Records</header>
                    <text>A
				third-party logistics provider shall keep records of the activities described
				in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:4/sp:A/cl:i/scl:I" proposed="true">subclauses (I)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:4/sp:A/cl:i/scl:II" proposed="true">(II) of clause (i)</cato:entity-ref>, as such subclauses relate to a
				suspect product, for not less than 6 years after the conclusion of the
				investigation.</text>
									</clause>
                </subparagraph>
                <subparagraph id="id6f2ffcaf4bf0405685304411704d1b2e">
                  <enum>(B)</enum>
                  <header>Illegitimate
				product</header>
									<clause id="id388659b378ab4c458275b3e38e424f63">
                    <enum>(i)</enum>
                    <header>In
				general</header>
                    <text>Upon determining, in coordination with the manufacturer,
				that a product in the possession or control of a third-party logistics provider
				is an illegitimate product, the third-party logistics provider shall—</text>
										<subclause id="id6961fe83646e43ab887210b0c29943cf">
                      <enum>(I)</enum>
                      <text>promptly notify
				the owner of such product of the need to disposition such product; and</text>
										</subclause>
                    <subclause id="id5fa2160095354280bae515276971c81b">
                      <enum>(II)</enum>
                      <text>promptly
				transfer possession of the product to the owner of such product to disposition
				the product.</text>
										</subclause>
                  </clause>
                  <clause id="id57e786d2abe442af985937c0b78d8e84">
                    <enum>(ii)</enum>
                    <header>Making a
				notification</header>
                    <text>Upon determining that a product in the possession or
				control of the third-party logistics provider is an illegitimate product, the
				third-party logistics provider shall notify the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> not later than 24
				hours after making such determination.</text>
									</clause>
                  <clause id="id4e98d1b0b4c94888802d9a6e80f97b13">
                    <enum>(iii)</enum>
                    <header>Responding to
				a notification</header>
                    <text>Upon the receipt of a notification from the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, a third-party logistics provider shall identify all illegitimate
				product subject to such notification that is in the possession or control of
				the third-party logistics provider, including any product that is subsequently
				received, and shall perform the activities described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:4/sp:A" proposed="true">subparagraph
				(A)</cato:entity-ref>.</text>
									</clause>
                  <clause id="ideb96820a56ff4cb39ccf3208d7d4a760">
                    <enum>(iv)</enum>
                    <header>Terminating a
				notification</header>
                    <text>Upon making a determination, in consultation with
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and the owner of such product, that a notification is no longer
				necessary, a third-party logistics provider shall promptly terminate such
				notification.</text>
									</clause>
                  <clause id="idB8557A8FF924417CBE3037ED15D696E1">
                    <enum>(v)</enum>
                    <header>Records</header>
                    <text>A
				third-party logistics provider shall keep records of the activities described
				in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:4/sp:A/cl:i/scl:I" proposed="true">subclauses (I)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:4/sp:A/cl:i/scl:II" proposed="true">(II) of clause (i)</cato:entity-ref> as such subclauses relate to an
				illegitimate product for not less than 6 years after the conclusion of the
				disposition.</text>
									</clause>
                </subparagraph>
              </paragraph>
            </subsection>
            <subsection id="id4a17635c488f4ba7b15ebf394bbca3b3">
              <enum>(g)</enum>
              <header>Drop
				shipments</header>
              <text>This section shall not apply to any entity that does
				not physically handle, distribute, or store product. For purposes of this
				section, providing various administrative services, including processing of
				orders and payments, shall not by itself, be construed as being involved in the
				handling, distribution, or storage of a product. For purposes of this section,
				the term <quote>entity</quote> means a wholesale distributor, relabeler,
				repackager, or any other
				status.</text>
						</subsection>
          </section>
        </subchapter>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
		</section>
    <section id="id78139f99bfa44fd6bfe76849e3b3d206">
      <enum>3.</enum>
      <header>Enhanced drug
			 distribution security</header>
			<subsection id="idC0D563904EBC4704BF7365765D527416">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text display-inline="yes-display-inline">
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582" proposed="true">Section 582 of the
			 Federal Food, Drug, and Cosmetic Act</cato:entity-ref>, as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act/s:2" proposed="true">section 2</cato:entity-ref>, is amended by
			 adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="id59969741af6e427a9f1cb2699dcabf62" style="OLC">
					<subsection id="id1cad5ecabf194b0796eb75d91991a5a3">
            <enum>(h)</enum>
            <header>Enhanced drug
				distribution security</header>
						<paragraph id="id08dca4b9ec8149499795c59ea0bcae5a">
              <enum>(1)</enum>
              <header>In
				general</header>
              <text>On the date that is 10 years after the date of enactment
				of the <short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                </short-title>, the following interoperable, electronic tracing of product
				at the package level requirements shall go into effect:</text>
							<subparagraph id="ide440bf6050e141e3b4dafd2fe94ecb62">
                <enum>(A)</enum>
                <text>The transaction
				information and the transaction statements as required under this section shall
				be exchanged in a secure, interoperable, electronic manner in accordance with
				the standards established under the guidance issued pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:3" proposed="true">paragraphs (3)</cato:entity-ref>
				and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:4" proposed="true">(4) of subsection (i)</cato:entity-ref>, including any revision of such guidance issued in
				accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:5" proposed="true">paragraph (5)</cato:entity-ref> of such subsection.</text>
							</subparagraph>
              <subparagraph id="id7a6f1d3e7254443d8e92edd0a16a4d62">
                <enum>(B)</enum>
                <text>The transaction
				information required under this section shall include the product identifier at
				the package level for each package included in the transaction.</text>
							</subparagraph>
              <subparagraph id="id6e54d5038e1b4769a88b573d3ee667e3">
                <enum>(C)</enum>
                <text>Systems and
				processes for verification of product at the package level shall be required in
				accordance with the standards established under the guidance issued pursuant to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2" proposed="true">subsection (a)(2)</cato:entity-ref> and the guidances issued pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:2" proposed="true">paragraphs (2)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:3" proposed="true">(3)</cato:entity-ref>, and
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:4" proposed="true">(4) of subsection (i)</cato:entity-ref>, including any revision of such guidances issued in
				accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:5" proposed="true">paragraph (5)</cato:entity-ref> of such subsection, which may include the use of
				aggregation and inference as necessary.</text>
							</subparagraph>
              <subparagraph id="id76ad7d97f89e48ec93e179d68166ac70">
                <enum>(D)</enum>
                <text>The systems and
				processes necessary to promptly respond with the transaction information and
				transaction statement for a product upon a request by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> (or other
				appropriate Federal or State official) in the event of a recall or for the
				purposes of investigating a suspect product or an illegitimate product shall be
				required.</text>
							</subparagraph>
              <subparagraph id="id6f8d8c5d7de44124a5dd3e82dcf981ac">
                <enum>(E)</enum>
                <text>The systems and
				processes necessary to promptly facilitate gathering the information necessary
				to produce the transaction information for each transaction going back to the
				manufacturer, as applicable shall be required—</text>
								<clause id="id2710315DC397425494812E51F4FD02AE">
                  <enum>(i)</enum>
                  <text>in the event of a
				request by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> (or other appropriate Federal or State official), on
				account of a recall or for the purposes of investigating a suspect product or
				an illegitimate product; or</text>
								</clause>
                <clause id="id350C7F7FEC8D4FE699ADD919E4E89EA2">
                  <enum>(ii)</enum>
                  <text>in the event of
				a request by an authorized trading partner, in a secure manner that ensures the
				protection of confidential commercial information and trade secrets, for
				purposes of investigating a suspect product or assisting the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> (or
				other appropriate Federal or State official) with a request described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:1/sp:E/cl:i" proposed="true">clause
				(i)</cato:entity-ref>.</text>
								</clause>
              </subparagraph>
              <subparagraph id="id8d04fa00a38242fab1858f96da188978">
                <enum>(F)</enum>
                <text>Each person
				accepting a saleable return shall have systems and processes in place to allow
				acceptance of such product and may accept saleable returns only if such person
				can associate the saleable return product with the transaction information and
				transaction statement associated with that product.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="ida792bc0703d44fbeae6ed2579d0537b2">
              <enum>(2)</enum>
              <header>Compliance</header>
							<subparagraph id="id9b1077ae3109408d9030e441c74fafbc">
                <enum>(A)</enum>
                <header>Information
				maintenance agreement</header>
                <text>A dispenser shall be permitted to enter
				into a written agreement with a third party, including an authorized wholesale
				distributor, under which the third party shall confidentially maintain any
				information and statements required to be maintained under this section. If a
				dispenser enters into such an agreement, the dispenser shall maintain a copy of
				the written agreement and shall not be relieved of the obligations of the
				dispenser under this subsection.</text>
							</subparagraph>
              <subparagraph id="id4d2220111ab34a6ca02e50455b10f7e7">
                <enum>(B)</enum>
                <header>Alternative
				methods</header>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, taking into consideration the assessment
				conducted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3" proposed="true">paragraph (3)</cato:entity-ref>, shall provide for alternative methods of
				compliance with any of the requirements set forth in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:1" proposed="true">paragraph (1)</cato:entity-ref>,
				including—</text>
								<clause id="id44bb2774b3c9441caec8a491986dd0a3">
                  <enum>(i)</enum>
                  <text>establishing
				timelines for compliance by small businesses (including small business
				dispensers with 25 or fewer full-time employees) with such requirements, in
				order to ensure that such requirements do not impose undue economic hardship
				for small businesses, including small business dispensers for whom the criteria
				set forth in the assessment under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3" proposed="true">paragraph (3)</cato:entity-ref> is not met, if the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				determines that such requirements under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:1" proposed="true">paragraph (1)</cato:entity-ref> would result in undue
				economic hardship; and</text>
								</clause>
                <clause id="ida4416b70070a4a9090fc4913ad8d5bfa">
                  <enum>(ii)</enum>
                  <text>establishing a
				process by which a dispenser may request a waiver from any of the requirements
				set forth in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:1" proposed="true">paragraph (1)</cato:entity-ref> if the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines that such requirements
				would result in an undue economic hardship, which shall include a process for
				the biennial review and renewal of any such waiver.</text>
								</clause>
              </subparagraph>
            </paragraph>
            <paragraph id="idc116ed31a5b942fdafacfe142d47079b">
              <enum>(3)</enum>
              <header>Assessment</header>
							<subparagraph id="idedb3e3e9b1c24735a89cd2851b7bc001">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>Not later than the date that is 18 months after the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> issues the final guidance required under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i" proposed="true">subsection (i)</cato:entity-ref>, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall enter into contract with a private, independent consulting firm
				with expertise to conduct a technology and software assessment that looks at
				the feasibility of dispensers with 25 or fewer full-time employees conducting
				interoperable, electronic tracing of products at the package level. In no case
				may such assessment commence later than 7.5 years after the date of enactment
				of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>.</text>
							</subparagraph>
              <subparagraph id="idAFEF47DD7337440BAB205F1175E77B97">
                <enum>(B)</enum>
                <header>Condition</header>
                <text>As
				a condition of the award of the contract under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>, the private,
				independent consulting firm shall agree to consult with dispensers with 25 or
				fewer full-time employees when conducting the assessment under such
				subparagraph.</text>
							</subparagraph>
              <subparagraph id="id6e98f4618f9440f49f52e39c44ce578a">
                <enum>(C)</enum>
                <header>Content</header>
                <text>The
				assessment conducted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> shall assess whether—</text>
								<clause id="idf0cc61d562df4dbda9e070035fa0930d">
                  <enum>(i)</enum>
                  <text>the necessary
				software and hardware is readily accessible to such dispensers;</text>
								</clause>
                <clause id="idf644f736b7804fd9ae31f611af38f431">
                  <enum>(ii)</enum>
                  <text>the necessary
				software and hardware is not prohibitively expensive to obtain, install, and
				maintain for such dispensers; and</text>
								</clause>
                <clause id="id5e41e8847c0042ecbf2abab0e60db70c">
                  <enum>(iii)</enum>
                  <text>the necessary
				hardware and software can be integrated into business practices, such as
				interoperability with wholesale distributors, for such dispensers.</text>
								</clause>
              </subparagraph>
              <subparagraph id="idba9a9bd282004f3ba69b9c5a13a1c154">
                <enum>(D)</enum>
                <header>Publication</header>
                <text>The
				Secretary shall—</text>
								<clause id="id80519817c10a4229b39cda39c08b66e2">
                  <enum>(i)</enum>
                  <text>publish the
				statement of work for the assessment conducted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> for
				public comment prior to beginning the assessment;</text>
								</clause>
                <clause id="iddc52ea6ea0024666bef8fe48fa301bc9">
                  <enum>(ii)</enum>
                  <text>publish the
				final assessment for public comment not later than 30 calendar days after
				receiving such assessment; and</text>
								</clause>
                <clause id="id9a02f0fde2c247d3b898f068ce527c35">
                  <enum>(iii)</enum>
                  <text>hold a public
				meeting not later than 180 calendar days after receiving the final assessment
				at which public stakeholders may present their views on the assessment.</text>
								</clause>
              </subparagraph>
            </paragraph>
            <paragraph id="idbeb98a33f64d40caa7e73c41afc31ea6">
              <enum>(4)</enum>
              <header>Procedure</header>
              <text>Notwithstanding
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/5/553">
                  <external-xref legal-doc="usc" parsable-cite="usc/5/553">section 553</external-xref> of title 5, United States Code</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in promulgating any
				regulation pursuant to this section, shall—</text>
							<subparagraph id="id9729ac5b569a408fa21bd0d84e164352">
                <enum>(A)</enum>
                <text>provide
				appropriate flexibility by—</text>
								<clause id="idfb629951661b4ca587e5f37ecbe2bd66">
                  <enum>(i)</enum>
                  <text>not requiring the
				adoption of specific business systems for the maintenance and transmission of
				data;</text>
								</clause>
                <clause id="idbdb50c04292641f9a6051a5ab3af2c7e">
                  <enum>(ii)</enum>
                  <text>prescribing
				alternative methods of compliance for any of the requirements set forth in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:1" proposed="true">paragraph (1)</cato:entity-ref> or set forth in regulations implementing such requirements,
				including timelines—</text>
									<subclause id="id689b0a455432450a90e1152a96a72c00">
                    <enum>(I)</enum>
                    <text>for small
				businesses to comply with the requirements set forth in the regulations in
				order to ensure that such requirements do not impose undue economic hardship
				for small businesses (including small business dispensers for whom the criteria
				set forth in the assessment under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3" proposed="true">paragraph (3)</cato:entity-ref> is not met), if the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				determines that such requirements would result in undue economic hardship;
				and</text>
									</subclause>
                  <subclause id="id4aa1311e99d34973b83e3bf2dec1364b">
                    <enum>(II)</enum>
                    <text>which shall
				include establishing a process by which a dispenser may request a waiver from
				any of the requirements set forth in such regulations if the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				determines that such requirements would result in an undue economic hardship;
				and</text>
									</subclause>
                </clause>
                <clause id="ide5d93bd691534f3a8ba3409cdf4bb942">
                  <enum>(iii)</enum>
                  <text>taking into
				consideration—</text>
									<subclause id="id9b201a779f694c889c3c1e64eb030706">
                    <enum>(I)</enum>
                    <text>the results of
				pilot projects, including pilot projects pursuant to this section;</text>
									</subclause>
                  <subclause id="id4fdbebc1a56d4cab963d943f5fcaaa59">
                    <enum>(II)</enum>
                    <text>the public
				meetings held and related guidance documents issued under this section;</text>
									</subclause>
                  <subclause id="id31e35c1ca7ce49ddb1f465fe428327d3">
                    <enum>(III)</enum>
                    <text>the public
				health benefits of any additional regulations in comparison to the cost of
				compliance with such requirements, including on entities of varying sizes and
				capabilities;</text>
									</subclause>
                  <subclause id="id5ff76dce4d2243ddba522508aa0a1dc0">
                    <enum>(IV)</enum>
                    <text>the diversity of
				the pharmaceutical distribution supply chain by providing appropriate
				flexibility for each sector, including both large and small businesses;
				and</text>
									</subclause>
                  <subclause id="idb0a779c890ed4bb7941bc5f5783219d0">
                    <enum>(V)</enum>
                    <text>the assessment
				pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3" proposed="true">paragraph (3)</cato:entity-ref> with respect to small business dispensers, including
				related public comment and the public meeting, and requirements under this
				section;</text>
									</subclause>
                </clause>
              </subparagraph>
              <subparagraph id="id7c10a31624b044f198f728156038162a">
                <enum>(B)</enum>
                <text>issue a notice of
				proposed rulemaking that includes a copy of the proposed regulation;</text>
							</subparagraph>
              <subparagraph id="id6ca06c5183d74e5bbcabc0ef5ef9ef6c">
                <enum>(C)</enum>
                <text>provide a period
				of not less than 60 days for comments on the proposed regulation; and</text>
							</subparagraph>
              <subparagraph id="id77a9e190274545749ad17e84a100c0bd">
                <enum>(D)</enum>
                <text>publish the final
				regulation not less than 2 years prior to the effective date of the
				regulation.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection id="ideaac9677f4734df39a94fb252fc48e34">
            <enum>(i)</enum>
            <header>Guidance
				documents</header>
						<paragraph id="id29CA8E5838AB49DBA26AC0222B843105">
              <enum>(1)</enum>
              <header>In
				general</header>
              <text>For the purposes of facilitating the successful and
				efficient adoption of secure, interoperable product tracing at the package
				level in order to enhance drug distribution security and further protect the
				public health, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall issue the guidance documents as provided for
				in this subsection.</text>
						</paragraph>
            <paragraph id="id98c9539f840340358d0b85e7665567f6">
              <enum>(2)</enum>
              <header>Suspect and
				illegitimate product</header>
							<subparagraph id="id162068CC657541FEAE09F3A0659E6E00">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>Not later than 180 days after enactment of the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                  </short-title>,
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall issue a guidance document to aid trading partners in the
				identification of a suspect product and notification termination. Such guidance
				document shall—</text>
								<clause id="id3bfbe26c01fa4ae4a3ef5298b73f3fa9">
                  <enum>(i)</enum>
                  <text>identify specific
				scenarios that could significantly increase the risk of a suspect product
				entering the pharmaceutical distribution supply chain;</text>
								</clause>
                <clause id="idd8f9962fe03745548aaa943c4e807910">
                  <enum>(ii)</enum>
                  <text>provide
				recommendation on how trading partners may identify such product and make a
				determination if the product is a suspect product as soon as practicable;
				and</text>
								</clause>
                <clause id="idece122f8c2f14965a8ce454e98387d3b">
                  <enum>(iii)</enum>
                  <text>set forth the
				process by which manufacturers, repackagers, wholesale distributors,
				dispensers, and third-party logistics providers shall terminate notifications
				in consultation with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> regarding illegitimate product pursuant to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:4/sp:B" proposed="true">subsections (b)(4)(B)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:4/sp:B" proposed="true">(c)(4)(B)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:4/sp:B" proposed="true">(d)(4)(B)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4/sp:B" proposed="true">(e)(4)(B)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:f/sp:B" proposed="true">(f)(B)</cato:entity-ref>.</text>
								</clause>
              </subparagraph>
              <subparagraph id="id296C5DBC3AFF47EE825ED36658A2A547">
                <enum>(B)</enum>
                <header>Revised
				guidance</header>
                <text>If the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> revises the guidance issued under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:2/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall follow the procedure set forth in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:5" proposed="true">paragraph (5)</cato:entity-ref>.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id65a18a369da44f19b36fbc79ff21f09a">
              <enum>(3)</enum>
              <header>Unit level
				tracing</header>
							<subparagraph id="id855CC5F333294F4EBE9F7FE81D40286A">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>In order to enhance drug distribution security at the
				package level, not later than 18 months after conducting a public meeting on
				the system attributes necessary to enable secure tracing of product at the
				package level, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall issue a final guidance document that
				outlines and makes recommendations with respect to the system attributes
				necessary to enable secure tracing at the package level as required under the
				requirements established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h" proposed="true">subsection (h)</cato:entity-ref>. Such guidance document
				shall—</text>
								<clause id="id8afb11903c994533b90e807404f33db5">
                  <enum>(i)</enum>
                  <text>define the
				circumstances under which the sectors within the pharmaceutical distribution
				supply chain may, in the most efficient manner practicable, infer the contents
				of a case, pallet, tote, or other aggregate of individual packages or
				containers of product, from a product identifier associated with the case,
				pallet, tote, or other aggregate, without opening each case, pallet, tote, or
				other aggregate or otherwise individually scanning each package;</text>
								</clause>
                <clause id="idf158a7f65ec94948a40d7afcd4662ab7">
                  <enum>(ii)</enum>
                  <text>identify methods
				and processes to enhance secure tracing of product at the package level, such
				as enhanced verification activities, the use of aggregation and inference,
				processes that utilize the product identifiers to enhance tracing of product at
				the package level, or package security features; and</text>
								</clause>
                <clause id="id47F253528FC9451A91B654F61A0BE459">
                  <enum>(iii)</enum>
                  <text>ensure the
				protection of confidential commercial information and trade secrets.</text>
								</clause>
              </subparagraph>
              <subparagraph id="idC856CB9872C54F2482A5C2C884BF881D">
                <enum>(B)</enum>
                <header>Procedure</header>
                <text>In
				issuing the guidance under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:3/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>, and in revising such guidance, if
				applicable, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall follow the procedure set forth in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:5" proposed="true">paragraph
				(5)</cato:entity-ref>.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id9515753a3c3b4ad0b7c79f9c35adee52">
              <enum>(4)</enum>
              <header>Standards for
				interoperable data exchange</header>
							<subparagraph id="id00C847C7AEC64014BA496C59C494F570">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>In order to enhance secure tracing of a product at the
				package level, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, not later than 18 months after conducting a
				public meeting on the interoperable standards necessary to enhance the security
				of the pharmaceutical distribution supply chain, shall update the guidance
				issued pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2" proposed="true">subsection (a)(2)</cato:entity-ref>, as necessary and appropriate, and
				finalize such guidance document so that the guidance document—</text>
								<clause id="idec032e434c27483b8aa77c51a38dc8bc">
                  <enum>(i)</enum>
                  <text>identifies and
				makes recommendation with respect to the standards necessary for adoption in
				order to support the secure, interoperable electronic data exchange among the
				pharmaceutical distribution supply chain that comply with a form and format
				developed by a widely recognized international standards development
				organization;</text>
								</clause>
                <clause id="id774b670f020b407cbdf671c36a70e72c">
                  <enum>(ii)</enum>
                  <text>takes into
				consideration standards established pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2" proposed="true">subsection (a)(2)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505D">section
				505D</cato:entity-ref>;</text>
								</clause>
                <clause id="idf10e1522eb1b4296834d814eb8cdb412">
                  <enum>(iii)</enum>
                  <text>facilitates the
				creation of a uniform process or methodology for product tracing; and</text>
								</clause>
                <clause id="id7c368bfa92fd4939b0251ab9374fd639">
                  <enum>(iv)</enum>
                  <text>ensures the
				protection of confidential commercial information and trade secrets.</text>
								</clause>
              </subparagraph>
              <subparagraph id="id36A572DFC43C4353B233CFE18AD6F027">
                <enum>(B)</enum>
                <header>Procedure</header>
                <text>In
				issuing the guidance under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:4/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>, and in revising such guidance, if
				applicable, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall follow the procedure set forth in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:5" proposed="true">paragraph
				(5)</cato:entity-ref>.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id1D45A921BB7A40768F2AC70F5E71316A">
              <enum>(5)</enum>
              <header>Procedure</header>
              <text>In
				issuing or revising any guidance issued pursuant to this subsection or
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h" proposed="true">subsection (h)</cato:entity-ref>, except the initial guidance issued under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:2/sp:A" proposed="true">paragraph (2)(A)</cato:entity-ref>, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall—</text>
							<subparagraph id="id7fd9c754f0e24dbe98159ecd92932598">
                <enum>(A)</enum>
                <text>publish a notice
				in the Federal Register for a period not less than 30 days announcing that the
				draft or revised draft guidance is available;</text>
							</subparagraph>
              <subparagraph id="id62de2e5bf670443f8a64c8fc43f051f4">
                <enum>(B)</enum>
                <text>post the draft
				guidance document on the Internet Web site of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>
				and make such draft guidance document available in hard copy;</text>
							</subparagraph>
              <subparagraph id="idbd9338595cca4ebb9da25eb30345b5ae">
                <enum>(C)</enum>
                <text>provide an
				opportunity for comment and review and take into consideration any comments
				received;</text>
							</subparagraph>
              <subparagraph id="id50c46d0db007425ba3d6d81e05c4ed08">
                <enum>(D)</enum>
                <text>revise the draft
				guidance, as appropriate;</text>
							</subparagraph>
              <subparagraph id="id660384bc78c84ba38bb384865abc3788">
                <enum>(E)</enum>
                <text>publish a notice
				in the Federal Register for a period not less than 30 days announcing that the
				final guidance or final revised guidance is available;</text>
							</subparagraph>
              <subparagraph id="id4c543ed1bd2544c88c065e83fb40f9e2">
                <enum>(F)</enum>
                <text>post the final
				guidance document on the Internet Web site of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>
				and make such final guidance document available in hard copy; and</text>
							</subparagraph>
              <subparagraph id="id9dc9093e057e445fb408af36cb888cce">
                <enum>(G)</enum>
                <text>provide for an
				effective date of not earlier than 1 year after such guidance becomes
				final.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection id="id38121468d2b448efba1df9e6d5a83109">
            <enum>(j)</enum>
            <header>Public
				meetings</header>
						<paragraph id="id79021d74220c4ac6a0f5397aec1ee2f3">
              <enum>(1)</enum>
              <header>In
				general</header>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall hold not less than 3 public meetings
				to enhance the safety and security of the pharmaceutical distribution supply
				chain and provide for comment. The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may hold the first such public
				meeting not earlier than 1 year after the date of enactment of the
				<short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                </short-title>.
				In carrying out the public meetings described in this paragraph, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				shall—</text>
							<subparagraph id="idb154d2a9cba640f8811b29ce1887d5db">
                <enum>(A)</enum>
                <text>prioritize topics
				necessary to inform the issuance of the guidance described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:3" proposed="true">paragraphs (3)</cato:entity-ref>
				and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:4" proposed="true">(4) of subsection (i)</cato:entity-ref>; and</text>
							</subparagraph>
              <subparagraph id="id76ffe7679d8349d6a9fd5333d2f5f01a">
                <enum>(B)</enum>
                <text>take all measures
				reasonable and practicable to ensure the protection of confidential commercial
				information and trade secrets.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id2151a3ad36834631acc5d3c4665e50c5">
              <enum>(2)</enum>
              <header>Content</header>
              <text>Each
				of the following topics shall be addressed in at least one of the public
				meetings described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:j/p:1" proposed="true">paragraph (1)</cato:entity-ref>:</text>
							<subparagraph id="idc7235e5feec04bf6a2ed14e9dfc377ab">
                <enum>(A)</enum>
                <text>An assessment of
				the steps taken under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:b..f" proposed="true">subsections (b) through (f)</cato:entity-ref> to build capacity for a
				unit-level system, including the impact of the requirements of such subsections
				on—</text>
								<clause id="id4e5fc9517aac4ff99049bbf69a32c2fc">
                  <enum>(i)</enum>
                  <text>the ability of
				the health care system collectively to maintain patient access to
				medicines;</text>
								</clause>
                <clause id="id634426b9c50040a983afed92e824982d">
                  <enum>(ii)</enum>
                  <text>the scalability
				of such requirements, including as it relates to product lines; and</text>
								</clause>
                <clause id="id866640e2bb5243d6bceef37fedb2c717">
                  <enum>(iii)</enum>
                  <text>the capability
				of different sectors and subsectors, including both large and small businesses,
				to affix and utilize the product identifier.</text>
								</clause>
              </subparagraph>
              <subparagraph id="idfb7f3fb8e5254b758b0f05e0f035c4a1">
                <enum>(B)</enum>
                <text>The system
				attributes necessary to support the requirements set forth under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h" proposed="true">subsection
				(h)</cato:entity-ref>, including the standards necessary for adoption in order to support the
				secure, interoperable electronic data exchange among sectors within the
				pharmaceutical distribution supply chain.</text>
							</subparagraph>
              <subparagraph id="id66b9ec8eb372421bafe3735a13594475">
                <enum>(C)</enum>
                <text>Best practices in
				each of the different sectors within the pharmaceutical distribution supply
				chain to implement the requirements of this section.</text>
							</subparagraph>
              <subparagraph id="idf5f5d479e03d4c95b322b74def3f2a69">
                <enum>(D)</enum>
                <text>The costs and
				benefits of the implementation of this section, including the impact on each
				pharmaceutical distribution supply chain sector and on public health.</text>
							</subparagraph>
              <subparagraph id="id06390ff276a5401a81124cfd477d73f7">
                <enum>(E)</enum>
                <text>Whether
				electronic tracing requirements, including tracing of product at the package
				level are feasible, cost-effective and needed to protect public health.</text>
							</subparagraph>
              <subparagraph id="ida902ab4eb527488a84eba03a440c1a15">
                <enum>(F)</enum>
                <text>The systems and
				processes needed to utilize the product identifiers to enhance tracing of
				product at the package level.</text>
							</subparagraph>
              <subparagraph id="idbd44303ab3504387b853ffa8cdd9a95a">
                <enum>(G)</enum>
                <text>The technical
				capabilities and legal authorities, if any, needed to establish an
				interoperable, electronic system that provides for tracing of product at the
				package level.</text>
							</subparagraph>
              <subparagraph id="id0f363b55aea343239a29ee07c7730294">
                <enum>(H)</enum>
                <text>The impact that
				such additional requirements would have on patient safety, the drug supply,
				cost and regulatory burden, and timely patient access to prescription
				drugs.</text>
							</subparagraph>
              <subparagraph id="idc409502a5ec643a983b5737d3b6192c7">
                <enum>(I)</enum>
                <text>Other topics, as
				determined appropriate by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection id="idd08923eb52834771be96461a551833cb">
            <enum>(k)</enum>
            <header>Pilot
				projects</header>
						<paragraph id="id30a3fb82bf61462da7f199441cc50fb5">
              <enum>(1)</enum>
              <header>In
				general</header>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall establish 1 or more pilot projects,
				in coordination with authorized manufacturers, repackagers, wholesale
				distributors, third-party logistics providers, and dispensers, to explore and
				evaluate methods to enhance the safety and security of the pharmaceutical
				distribution supply chain. Such projects shall build upon efforts, in existence
				as of the date of enactment of the <short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug
				Supply Chain Security Act</cato:entity-ref>
                </short-title>, to enhance the safety and security of
				the pharmaceutical distribution supply chain, take into consideration any pilot
				projects conducted prior to such date of enactment, and inform the draft and
				final guidance under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:3" proposed="true">paragraphs (3)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:4" proposed="true">(4) of subsection (i)</cato:entity-ref>.</text>
						</paragraph>
            <paragraph id="id22b17c10577444deb230af1c3e7fb92d">
              <enum>(2)</enum>
              <header>Content</header>
							<subparagraph id="id9d5be24ee59b40d9a6b4a52e3412db6d">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall ensure that the pilot projects under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:k/p:1" proposed="true">paragraph (1)</cato:entity-ref> reflect the diversity of the pharmaceutical distribution supply
				chain and that the pilot projects, when taken as a whole, include participants
				representative of every sector, including both large and small
				businesses.</text>
							</subparagraph>
              <subparagraph id="id2de13569c5a1440b84553e674fd1e23f">
                <enum>(B)</enum>
                <header>Project
				design</header>
                <text>The pilot projects under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:k/p:1" proposed="true">paragraph (1)</cato:entity-ref> shall be designed
				to—</text>
								<clause id="id578530bca2e54955b06bbf87a29dda82">
                  <enum>(i)</enum>
                  <text>utilize the
				product identifier for tracing of a product, which may include verification of
				the product identifier of a product, including the use of aggregation and
				inference;</text>
								</clause>
                <clause id="id55cfb481af6844fc8abb146631ff2d7a">
                  <enum>(ii)</enum>
                  <text>improve the
				technical capabilities of each sector and subsector to comply with systems and
				processes needed to utilize the product identifiers to enhance tracing of a
				product;</text>
								</clause>
                <clause id="idd3261d28fb5344edb342c5d1b7681ced">
                  <enum>(iii)</enum>
                  <text>identify system
				attributes that are necessary to implement the requirements established under
				this section; and</text>
								</clause>
                <clause id="id2f4688908a8f46f6a6b17f99658deb7a">
                  <enum>(iv)</enum>
                  <text>complete other
				activities as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>.</text>
								</clause>
              </subparagraph>
            </paragraph>
          </subsection>
          <subsection id="idc05159ec574444c581a497ee9fe7ba1d">
            <enum>(l)</enum>
            <header>Sunset</header>
            <text>The
				following requirements shall have no force or effect beginning on the date that
				is 10 years after the date of enactment of the
				<short-title>
                <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
              </short-title>:</text>
						<paragraph id="id3123aa85b6b7416c8926eef466d5cfd7">
              <enum>(1)</enum>
              <text>The provision and
				receipt of transaction history under this section.</text>
						</paragraph>
            <paragraph id="id2b6e7824e0c64b6d8c4e24d59b5d252c">
              <enum>(2)</enum>
              <text>The requirements
				set forth for returns under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:B/cl:i" proposed="true">subsection (c)(1)(B)(i)</cato:entity-ref>.</text>
						</paragraph>
          </subsection>
          <subsection id="idfd9de69cdb82416382686911558ef781">
            <enum>(m)</enum>
            <header>Rule of
				construction</header>
            <text>The requirements set forth in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:4" proposed="true">subsections (h)(4)</cato:entity-ref>,
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:j" proposed="true">(j)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:k" proposed="true">(k)</cato:entity-ref> shall not be construed as a condition, prohibition, or precedent
				for precluding or delaying the provisions becoming effective pursuant to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:h" proposed="true">subsection
				(h)</cato:entity-ref>.</text>
					</subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
    </section>
    <section id="id789f8b5aea394bc2b27455cbec46e78f">
      <enum>4.</enum>
      <header>National
			 licensure standards for wholesale distributors</header>
			<subsection id="idF163EB8B15DE4D9B8C40936395CD38B0">
        <enum>(a)</enum>
        <header>Amendments</header>
				<paragraph id="idE65EFFEF2DCF4771AE87AE5BD0B752E3">
          <enum>(1)</enum>
          <header>License
			 requirement</header>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e">Section 503(e) of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/353">
                <cato:entity-ref entity-type="uscode" value="usc/21/353/e">21 U.S.C. 353(e)</cato:entity-ref>
              </external-xref>)</cato:entity> is amended by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1">paragraphs (1)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:2">(2)</cato:entity-ref>, and
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:3">(3)</cato:entity-ref> and inserting the following:</text>
					<quoted-block display-inline="no-display-inline" id="idE59F80AE41874797A7084BC21C70C1F4" style="OLC">
						<paragraph id="id1f9b9420c75a410d84d4a15ee04215b9">
              <enum>(1)</enum>
              <header>License
				requirement</header>
              <text>Subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:583" proposed="true">section 583</cato:entity-ref>:</text>
							<subparagraph id="id94C04F772A5F4C3194709FA7A3629F9C">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>No person may engage in wholesale distribution of a drug
				subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1">subsection (b)(1)</cato:entity-ref> in any State unless such person—</text>
								<clause id="id19980E335D834395B7DA67CA87AFB525">
                  <enum>(i)</enum>
                  <subclause commented="no" display-inline="yes-display-inline" id="id18E884A392924D38AF01B9C692083F05">
                    <enum>(I)</enum>
                    <text>is licensed by the
				State from which the drug is distributed; or</text>
									</subclause>
                  <subclause id="id720C82711F8042E48DAD17BAE5DE3BA2" indent="up1">
                    <enum>(II)</enum>
                    <text>if the State from which the drug
				distributed has not established a licensure requirement, is licensed by the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>; and</text>
									</subclause>
                </clause>
                <clause id="id4B20BB6AF09F40479E936EFACF05A47B">
                  <enum>(ii)</enum>
                  <text>if the drug is
				distributed interstate, is licensed by the State into which the drug is
				distributed if the State into which the drug is distributed requires the
				licensure of a person that distributes drugs into the State.</text>
								</clause>
              </subparagraph>
              <subparagraph id="id703C3BAC78C54122A834F2D51A05E904">
                <enum>(B)</enum>
                <header>License
				standards</header>
                <text>Each Federal and State license described in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> shall meet the standards, terms, and conditions established by
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:583" proposed="true">section 583</cato:entity-ref>.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id226da65c15e74cb6aa56baf3b5cac42c">
              <enum>(2)</enum>
              <header>Licensure
				reporting and database</header>
							<subparagraph id="id817CB5D3D91245D195821750EF6072C2">
                <enum>(A)</enum>
                <header>Licensure
				reporting</header>
                <text>Beginning 1 year after the date of enactment of the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                  </short-title>,
				any person who owns or operates an establishment that engages in wholesale
				distribution shall report to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, on an annual basis pursuant to a
				schedule determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>—</text>
								<clause id="idd24ce812c0f74aa3bfeb566978714857">
                  <enum>(i)</enum>
                  <text>each State by
				which the person is licensed and the appropriate identification number of each
				such license; and</text>
								</clause>
                <clause id="idbde6c4431ca740c9acff78918171b271">
                  <enum>(ii)</enum>
                  <text>the name and
				address of each facility at which, and all trade names under which, the person
				conducts business.</text>
								</clause>
              </subparagraph>
              <subparagraph id="idef744454ee784b509ecb8b22df336ca8">
                <enum>(B)</enum>
                <header>Database</header>
                <text>Not
				later than 1 year after the date of enactment of the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                  </short-title>,
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall establish a database of licensed wholesale distributors.
				Such database shall—</text>
								<clause id="id01499591fc1c41cca33f1a2c2e6110ae">
                  <enum>(i)</enum>
                  <text>identify each
				wholesale distributor by name, contact information, and each State where such
				wholesale distributor is appropriately licensed to engage in wholesale
				distribution;</text>
								</clause>
                <clause id="ida913b40d8b254decbf1baac6dcc1a6b4">
                  <enum>(ii)</enum>
                  <text>be available to
				the public on the Internet Web site of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>;
				and</text>
								</clause>
                <clause id="id2e64041c8a6846389028dd1d0e4cba5b">
                  <enum>(iii)</enum>
                  <text>be regularly
				updated on a schedule determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>.</text>
								</clause>
              </subparagraph>
            </paragraph>
            <paragraph id="id51c6f01400a64b11af086c037a589bd5">
              <enum>(3)</enum>
              <header>Costs</header>
							<subparagraph id="id34610194be604e30b19e7422402a3f1b">
                <enum>(A)</enum>
                <header>Authorized
				licensure fees of secretary</header>
                <text>If a State does not establish a
				licensing program for persons engaged in the wholesale distribution of a drug
				subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b">subsection (b)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall license a person engaged in
				wholesale distribution located in such State and may collect a reasonable fee
				in such amount necessary to reimburse the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> for costs associated with
				establishing and administering the licensure program and conducting periodic
				inspections under this section. The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall adjust fee rates as needed
				on an annual basis to generate only the amount of revenue needed to perform
				this service. Fees authorized under this paragraph shall be collected and
				available for obligation only to the extent and in the amount provided in
				advance in appropriations Acts. Such fees are authorized to remain available
				until expended.</text>
							</subparagraph>
              <subparagraph id="id06e5fed979c84b34902fd983939bf7f6">
                <enum>(B)</enum>
                <header>State licensing
				fees</header>
                <text>Nothing in this Act shall prohibit States from collecting
				fees from wholesale distributors in connection with State licensing of such
				distributors.</text>
							</subparagraph>
            </paragraph>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
        <paragraph id="id11009d86cc2446b78c2b292000c4eb56">
          <enum>(2)</enum>
          <header>Wholesale
			 distribution</header>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e">Section 503(e) of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/353">
                <cato:entity-ref entity-type="uscode" value="usc/21/353/e">21 U.S.C. 353(e)</cato:entity-ref>
              </external-xref>)</cato:entity>, as amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act/s:4/ss:a" proposed="true">subsection (a)</cato:entity-ref>, is further
			 amended by adding at the end the following:</text>
					<quoted-block display-inline="no-display-inline" id="idf7f32e3dc5684e008752f21a112ceeaf" style="OLC">
						<paragraph id="ida478ee3d2d034bac932d45cbc6f159aa">
              <enum>(4)</enum>
              <text>For the purposes
				of this subsection and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:d">subsection (d)</cato:entity-ref>, the term <term>wholesale
				distribution</term> means the distribution of a drug subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b">subsection (b)</cato:entity-ref>
				to a person other than a consumer or patient, or receipt of a drug subject to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b">subsection (b)</cato:entity-ref> by a person other than the consumer or patient, but does not
				include—</text>
							<subparagraph id="idc79eccaff24c473a99e23975a1473af3">
                <enum>(A)</enum>
                <text>intracompany
				distribution of any drug between members of an affiliated group (as defined in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:1504/ss:a">
                    <external-xref legal-doc="usc" parsable-cite="usc/26/1504">section 1504(a)</external-xref> of the Internal Revenue Code of 1986</cato:entity-ref>);</text>
							</subparagraph>
              <subparagraph id="id3a39e320bef9462aafafb44b452925ce">
                <enum>(B)</enum>
                <text>the distribution
				of a drug, or an offer to distribute a drug among hospitals or other health
				care entities which are under common control;</text>
							</subparagraph>
              <subparagraph id="ida591e644579c405fb92add0a6ea75b05">
                <enum>(C)</enum>
                <text>the distribution
				of a drug or an offer to distribute a drug for emergency medical reasons,
				including a public health emergency declaration pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319">section 319 of the
				Public Health Service Act</cato:entity-ref>, except that a drug shortage not caused by a public
				health emergency shall not constitute an emergency medical reason;</text>
							</subparagraph>
              <subparagraph id="ide13af1043ccf436d8e0ede916a13e3a2">
                <enum>(D)</enum>
                <text>the dispensing of
				a drug pursuant to a valid prescription executed in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1">section
				503(b)(1)</cato:entity-ref>;</text>
							</subparagraph>
              <subparagraph id="id3f82d5d180134a93943f0db938f9824b">
                <enum>(E)</enum>
                <text>the distribution
				of minimal quantities of drug by a licensed retail pharmacy to a licensed
				practitioner for office use;</text>
							</subparagraph>
              <subparagraph id="idd24555e2bc024c638a9dd97427b12bbb">
                <enum>(F)</enum>
                <text>the distribution
				of a drug or an offer to distribute a drug by a charitable organization to a
				nonprofit affiliate of the organization to the extent otherwise permitted by
				law;</text>
							</subparagraph>
              <subparagraph id="idbb2dab14f3ca4800be5dd09daf6ed2a2">
                <enum>(G)</enum>
                <text>the purchase or
				other acquisition by a dispenser, hospital, or other health care entity of a
				drug for use by such dispenser, hospital, or other health care entity;</text>
							</subparagraph>
              <subparagraph id="ida081e584f3054b3ba2c048d29a499cc1">
                <enum>(H)</enum>
                <text>the distribution
				of a drug by the manufacturer of such drug;</text>
							</subparagraph>
              <subparagraph id="id8cee228766d34455b12a16972238a725">
                <enum>(I)</enum>
                <text>the receipt or
				transfer of a drug by an authorized third-party logistics provider provided
				that such third-party logistics provider does not take ownership of the
				drug;</text>
							</subparagraph>
              <subparagraph id="id5d98b8ca500d4e748a54fb7c0c06ae6b">
                <enum>(J)</enum>
                <text>a common carrier
				that transports a drug, provided that the common carrier does not take
				ownership of the drug;</text>
							</subparagraph>
              <subparagraph id="id683e519ecf1d41179ecbf8bdb7286ce5">
                <enum>(K)</enum>
                <text>the distribution
				of a drug, or an offer to distribute a drug by an authorized repackager that
				has taken ownership or possession of the drug and repacks it in accordance with
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582/ss:e" proposed="true">section 582(e)</cato:entity-ref>;</text>
							</subparagraph>
              <subparagraph id="ide3877406299043c9b84a3112f49c81b2">
                <enum>(L)</enum>
                <text>saleable drug
				returns when conducted by a dispenser;</text>
							</subparagraph>
              <subparagraph id="id11d483b11ba940538d350dc24667b70a">
                <enum>(M)</enum>
                <text>the distribution
				of a medical convenience kit which is a collection of finished drug or biologic
				products assembled in kit form strictly for the convenience of the purchaser or
				user if—</text>
								<clause id="id2efebdd7fe4c4c998b4375b2c8398913">
                  <enum>(i)</enum>
                  <text>the medical
				convenience kit is assembled in an establishment that is registered with the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> as a device manufacturer in accordance with
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:510/ss:b/p:2">section 510(b)(2)</cato:entity-ref>;</text>
								</clause>
                <clause id="id437594fc280e484399e8324e9008cffa">
                  <enum>(ii)</enum>
                  <text>the person who
				manufactures the medical convenience kit purchased the finished drug or
				biologic product contained in the medical convenience kit directly from the
				pharmaceutical manufacturer or from a wholesale distributor that purchased the
				product directly from the pharmaceutical manufacturer;</text>
								</clause>
                <clause id="id4e2a19b0e92c4e41ad429d3a548eae98">
                  <enum>(iii)</enum>
                  <text>the person who
				manufactures a medical convenience kit does not alter the primary container or
				label of the product as purchased from the manufacturer or wholesale
				distributor;</text>
								</clause>
                <clause id="idf4a4d3140a21413f87d08f938789c2ad">
                  <enum>(iv)</enum>
                  <text>the medical
				convenience kit does not contain a controlled substance that appears in a
				schedule contained in the <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                      <cato:entity-ref entity-type="act" value="Comprehensive Drug Abuse Prevention and Control Act of 1970">Comprehensive Drug Abuse Prevention and Control Act
				of 1970</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/801,/etseq">
                        <external-xref legal-doc="usc" parsable-cite="usc/21/801">21 U.S.C. 801</external-xref>, et seq.</cato:entity-ref>)</cato:entity>; and</text>
								</clause>
                <clause commented="no" id="id60b2b24f94fa449c8d79559c07de7633">
                  <enum>(v)</enum>
                  <text>the products
				contained in the medical convenience kit are—</text>
									<subclause commented="no" id="id2872581e13b74c19acf04cef0614597b">
                    <enum>(I)</enum>
                    <text>intravenous
				solutions intended for the replenishment of fluids and electrolytes;</text>
									</subclause>
                  <subclause commented="no" id="idb2b849902aaf4b64ad56cac36c26e1fc">
                    <enum>(II)</enum>
                    <text>drugs intended
				to maintain the equilibrium of water and minerals in the body;</text>
									</subclause>
                  <subclause commented="no" id="id671a02180b43452db2d06448ab53d143">
                    <enum>(III)</enum>
                    <text>drugs intended
				for irrigation or reconstitution;</text>
									</subclause>
                  <subclause commented="no" id="id79fa8a19b3a74d7f91d579112a116fae">
                    <enum>(IV)</enum>
                    <text>anesthetics;</text>
									</subclause>
                  <subclause commented="no" id="ida72d9cdd449248ebb076a9b815688da4">
                    <enum>(V)</enum>
                    <text>anticoagulants;</text>
									</subclause>
                  <subclause commented="no" id="iddaee9f8b38ce41d48ff2284062e4c285">
                    <enum>(VI)</enum>
                    <text>vasopressors;
				or</text>
									</subclause>
                  <subclause commented="no" id="id35ad17f23d81430d8f57e502c64109df">
                    <enum>(VII)</enum>
                    <text>sympathicomimetics;</text>
									</subclause>
                </clause>
              </subparagraph>
              <subparagraph id="ide517608bc6584d4d8031582487c0b19b">
                <enum>(N)</enum>
                <text>the distribution
				of an intravenous drug that, by its formulation, is intended for the
				replenishment of fluids and electrolytes (such as sodium, chloride, and
				potassium) or calories (such as dextrose and amino acids);</text>
							</subparagraph>
              <subparagraph id="idf63e9d00cf4049dead2dc378940f8aa4">
                <enum>(O)</enum>
                <text>the distribution
				of an intravenous drug used to maintain the equilibrium of water and minerals
				in the body, such as dialysis solutions;</text>
							</subparagraph>
              <subparagraph id="idd0860c0bac4347a4bf9969f3ae619c39">
                <enum>(P)</enum>
                <text>the distribution
				of a drug that is intended for irrigation or reconstitution, or sterile water,
				whether intended for such purposes or for injection;</text>
							</subparagraph>
              <subparagraph id="id4c5ffb8b688a44768d3f2d816ad36212">
                <enum>(Q)</enum>
                <text>the distribution
				of compressed medical gas, defined as any substance in its gaseous or cryogenic
				liquid form that meets medical purity standards and has application in a
				medical or homecare environment, including oxygen and nitrous oxide;</text>
							</subparagraph>
              <subparagraph id="idc431b65261d040d88ce649191943bd06">
                <enum>(R)</enum>
                <text>facilitating the
				distribution of a product by providing solely administrative services,
				including processing of orders and payments; or</text>
							</subparagraph>
              <subparagraph id="idd779fc7ae9d5451eb816c8ebdeb83895">
                <enum>(S)</enum>
                <text>the transfer of a
				product by a hospital or other health care entity to a repackager registered
				under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:510">section 510</cato:entity-ref> for the purpose of repackaging the drug for use by that
				hospital, or other health care entity and other health care entities that are
				under common control, if ownership of the drug remains with the hospital or
				other health care entity at all
				times.</text>
							</subparagraph>
            </paragraph>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
        <paragraph id="idcf5d8069c9c945e6bd30c70728fc2ee8">
          <enum>(3)</enum>
          <header>Third-party
			 logistics providers</header>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e">Section 503(e) of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/353">
                <cato:entity-ref entity-type="uscode" value="usc/21/353/e">21 U.S.C. 353(e)</cato:entity-ref>
              </external-xref>)</cato:entity>, as amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act/s:4/ss:a" proposed="true">subsection (a)</cato:entity-ref>, is further
			 amended by adding at the end the following:</text>
					<quoted-block display-inline="no-display-inline" id="id1D5792219B93429E902772B8023A4176" style="OLC">
						<paragraph id="id1800c5d7a9d54898bc802568ddef8c8e">
              <enum>(5)</enum>
              <header>Third-party
				logistics providers</header>
              <text>Notwithstanding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1..4" proposed="true">paragraphs (1) through (4)</cato:entity-ref>,
				each entity that meets the definition of a third-party logistics provider under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581/p:22" proposed="true">section 581(22)</cato:entity-ref> shall obtain a license as a third-party logistics provider as
				described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584/ss:a" proposed="true">section 584(a)</cato:entity-ref> and is not required to obtain a license as a
				wholesale distributor if the entity never assumes an ownership interest in the
				product it
				handles.</text>
						</paragraph>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
        <paragraph id="id053cdf2332204a4b9e8eeeaca6a0cceb">
          <enum>(4)</enum>
          <header>Licensure
			 standards</header>
          <text>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/ch:V/sch:H" proposed="true">Subchapter H of chapter V of the Federal Food, Drug,
			 and Cosmetic Act</cato:entity-ref>, as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act/s:2" proposed="true">section 2</cato:entity-ref>, is amended by adding at the end the
			 following:</text>
					<quoted-block display-inline="no-display-inline" id="id516D324C4FF142E6BEFB150F62603583" style="OLC">
						<section id="id46e4fa2f7fd545359f0f3acd8ef6cb3d">
              <enum>583.</enum>
              <header>National
				licensure standards for wholesale distributors</header>
							<subsection commented="no" id="id60d28eeab53c4b9aa9dcbfa88bc35ebd">
                <enum>(a)</enum>
                <header>In
				general</header>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall, not later than 2 years after the
				date of enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain
				Security Act</cato:entity-ref>
                  </short-title>, by regulation establish minimum standards, terms,
				and conditions for the licensing of persons under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1" proposed="true">section 503(e)(1)</cato:entity-ref> (as amended
				by the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                  </short-title>), including the revocation, reissuance, and renewal of such
				license.</text>
							</subsection>
              <subsection id="idc219932a86784bbda65399a4e9ce6e5d">
                <enum>(b)</enum>
                <header>Content</header>
                <text>The
				standards established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:583/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall apply to all State and Federal
				licenses described under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1" proposed="true">section 503(e)(1)</cato:entity-ref> (as amended by the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                  </short-title>)
				and shall prescribe minimum requirements for—</text>
								<paragraph id="idc529fa56de3e49fe90858c657fbfd58d">
                  <enum>(1)</enum>
                  <text>the storage and
				handling of such drugs, including facility requirements;</text>
								</paragraph>
                <paragraph id="idd02f48899cd047f19f45d4c3bab90e61">
                  <enum>(2)</enum>
                  <text>the establishment
				and maintenance of records of the distributions of such drugs;</text>
								</paragraph>
                <paragraph id="id46c9dfed5c1b42479b6bd92a0d3475cd">
                  <enum>(3)</enum>
                  <text>the furnishing of
				a bond or other equivalent means of security if—</text>
									<subparagraph id="id793d35dcca9f45779088afa9473ba56a">
                    <enum>(A)</enum>
                    <text>an applicant that
				is not a government owned and operated wholesale distributor, for the issuance
				or renewal of a wholesale distributor license shall submit a surety bond of one
				hundred thousand dollars or other equivalent means of security acceptable to
				the State;</text>
									</subparagraph>
                  <subparagraph id="idc19542a0291243b98dfd386c006b507d">
                    <enum>(B)</enum>
                    <text>for purposes of
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:583/ss:b/p:3/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>, the State or other applicable authority may accept a surety
				bond less than $100,000 if the annual gross receipts of the previous tax year
				for the wholesaler is $10,000,000 or less, in which case the surety bond shall
				be $25,000; and</text>
									</subparagraph>
                  <subparagraph id="iddb48dfb4e9a740a494f458a955c32325">
                    <enum>(C)</enum>
                    <text>if a wholesale
				distributor can provide evidence that it possesses the required bond in a
				State, the requirement for a bond in another State is waived;</text>
									</subparagraph>
                </paragraph>
                <paragraph id="id461ea4d1abfb4d0b81f633194a9ed114">
                  <enum>(4)</enum>
                  <text>mandatory
				background checks and fingerprinting of facility managers or designated
				representatives;</text>
								</paragraph>
                <paragraph id="idc651125472124b0f9b27850ae2f81cc2">
                  <enum>(5)</enum>
                  <text>the establishment
				and implementation of qualifications for key personnel;</text>
								</paragraph>
                <paragraph id="id65a714360dc64371940156fd7c77dd22">
                  <enum>(6)</enum>
                  <text>the mandatory
				physical inspection of any facility to be used in wholesale distribution within
				a reasonable time frame from the initial application of the facility and to be
				conducted by the licensing authority or by the State, consistent with
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:583/ss:c" proposed="true">subsection (c)</cato:entity-ref>; and</text>
								</paragraph>
                <paragraph id="id3db3f924680147a6a40d3cafe08243a8">
                  <enum>(7)</enum>
                  <text>in accordance
				with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:583/ss:d" proposed="true">subsection (d)</cato:entity-ref>, the prohibition of certain persons from receiving or
				maintaining licensure for wholesale distribution.</text>
								</paragraph>
              </subsection>
              <subsection id="id2d1a7a1e8c244be399aa79a3ebc74df3">
                <enum>(c)</enum>
                <header>Inspections</header>
                <text>To
				satisfy the inspection requirement the Federal or State licensing authority may
				conduct the inspection, or may accept an inspection by the State in which the
				facility is located, or by a third-party accreditation or inspection service
				approved by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or the State licensing such wholesale
				distributor.</text>
							</subsection>
              <subsection id="id738438e74edc4e0a86ab704cffb7ac39">
                <enum>(d)</enum>
                <header>Prohibited
				persons</header>
                <text>The standards established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:583/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall
				include requirements to prohibit a person from receiving or maintaining
				licensure for wholesale distribution if the person—</text>
								<paragraph id="id575ea202f64d45a98ddd80db1534899c">
                  <enum>(1)</enum>
                  <text>has been
				convicted of any felony for conduct relating to wholesale distribution, any
				felony violation of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:i">subsection (i)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:k">(k) of section 301</cato:entity-ref>, or any felony
				violation of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/18/1365">
                      <external-xref legal-doc="usc" parsable-cite="usc/18/1365">section 1365</external-xref> of title 18, United States Code</cato:entity-ref>, relating to product
				tampering; or</text>
								</paragraph>
                <paragraph id="ide78613db1a91449cb3b3ded090f0795e">
                  <enum>(2)</enum>
                  <text>has engaged in a
				pattern of violating the requirements of this section, or State requirements
				for licensure, that presents a threat of serious adverse health consequences or
				death to humans.</text>
								</paragraph>
              </subsection>
              <subsection id="idbd61fa305be74bd097e85686bcf46e7e">
                <enum>(e)</enum>
                <header>Requirements</header>
                <text>The
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in promulgating any regulation pursuant to this section, shall,
				notwithstanding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/5/553">
                    <external-xref legal-doc="usc" parsable-cite="usc/5/553">section 553</external-xref> of title 5, United States Code</cato:entity-ref>—</text>
								<paragraph id="ide24b23c32e984958bf65d23d23dcb9ac">
                  <enum>(1)</enum>
                  <text>issue a notice of
				proposed rulemaking that includes a copy of the proposed regulation;</text>
								</paragraph>
                <paragraph id="idb239630a230b4e7da3744ac0d6f56a93">
                  <enum>(2)</enum>
                  <text>provide a period
				of not less than 60 days for comments on the proposed regulation; and</text>
								</paragraph>
                <paragraph id="id74c7d373bd1540ee8403c1310f6995fa">
                  <enum>(3)</enum>
                  <text>provide that the
				final regulation take effect on the date that is 2 years after the date such
				final regulation is
				published.</text>
								</paragraph>
              </subsection>
            </section>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </subsection>
      <subsection id="idEF99B87EDB714ABE9C72336D3ECEBB20">
        <enum>(b)</enum>
        <header>Conforming
			 amendments</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:d">Section 503(d) of the Federal Food, Drug, and Cosmetic
			 Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/353">
              <cato:entity-ref entity-type="uscode" value="usc/21/353/d">21 U.S.C. 353(d)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended—</text>
				<paragraph id="idA5C3443C928C4F0F9751F383F10CF095">
          <enum>(1)</enum>
          <text>by striking
			 <quote>authorized distributor of record</quote> each place such term appears
			 and inserting <quote>wholesale distributor</quote>; and</text>
				</paragraph>
        <paragraph id="id37F6BB667D9D496E8FF1E05135465245">
          <enum>(2)</enum>
          <text>by striking
			 <quote>authorized distributors of record</quote> each place such term appears
			 and inserting <quote>wholesale distributors</quote>.</text>
				</paragraph>
      </subsection>
      <subsection id="id1630CEF5641647AFB44BB7B93F2EC745">
        <enum>(c)</enum>
        <header>Effective
			 date</header>
        <text>The amendments made by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act/s:4/ss:a" proposed="true">subsections (a)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act/s:4/ss:b" proposed="true">(b)</cato:entity-ref> shall take
			 effect on the day that is 1 year after the date of enactment of this
			 Act.</text>
			</subsection>
    </section>
    <section id="idd67351dddf004eff9e0b4ae9d0e45e95">
      <enum>5.</enum>
      <header>National
			 licensure standards for third-party logistics providers; uniform national
			 policy</header>
      <text display-inline="no-display-inline">
        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/ch:V/sch:H">Subchapter H of chapter
			 V of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref>, as amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act/s:4" proposed="true">section 4</cato:entity-ref>, is
			 further amended by adding at the end the following:</text>
			<quoted-block display-inline="no-display-inline" id="id95B0C9A968964BABA476B1E3B63FF509" style="OLC">
				<section id="id8b3909584f3a465e98244ef276148f3b">
          <enum>584.</enum>
          <header>National
				licensure standards for third-party logistics providers</header>
					<subsection id="idabf3370a48634d77a1cb0056f4fc2961">
            <enum>(a)</enum>
            <header>License
				requirements</header>
            <text>No third-party logistics provider in any State may
				conduct activities in any State unless each facility of such third-party
				logistics provider—</text>
						<paragraph id="idf77d0df1dc664d72aa5123cd4b0f25b9">
              <enum>(1)</enum>
              <subparagraph commented="no" display-inline="yes-display-inline" id="idC6793948DC164CD7A2D21B34B6041F51">
                <enum>(A)</enum>
                <text>is licensed by the
				State from which the drug is distributed by the third-party logistics provider,
				in accordance with the regulations promulgated under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584/ss:d" proposed="true">subsection (d)</cato:entity-ref>; or</text>
							</subparagraph>
              <subparagraph id="id827BCE792A2C48E09008467148563BB7" indent="up1">
                <enum>(B)</enum>
                <text>if the State from which the drug
				distributed by the third-party logistics provider has not established a
				licensure requirement, is licensed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in accordance with the
				regulations promulgated under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584/ss:d" proposed="true">subsection (d)</cato:entity-ref>; and</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id8AA0272AD88C4E76920056285294B21D">
              <enum>(2)</enum>
              <text>if the drug is
				distributed interstate, is licensed by the State into which the drug is
				distributed by the third-party logistics provider if such State licenses
				third-party logistics providers that distribute drugs into the State and the
				third-party logistics provider is not licensed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> as described in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584/ss:a/p:1/sp:A/cl:ii" proposed="true">subparagraph (A)(ii)</cato:entity-ref>.</text>
						</paragraph>
          </subsection>
          <subsection id="id6f85ec55acfa403090d05876b5abedd3">
            <enum>(b)</enum>
            <header>Licensure
				reporting</header>
            <text>Beginning 1 year after the date of enactment of the
				<short-title>
                <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
              </short-title>,
				a facility of a third-party logistics provider shall report to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>,
				on an annual basis pursuant to a schedule determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>—</text>
						<paragraph id="idea48483d4b054dafacf3a3d531c9c461">
              <enum>(1)</enum>
              <text>the State by
				which the facility is licensed and the appropriate identification number of
				such license; and</text>
						</paragraph>
            <paragraph id="id83fed44bd75f4b7293745dad14757520">
              <enum>(2)</enum>
              <text>the name and
				address of the facility, and all trade names under which, such facility
				conducts business.</text>
						</paragraph>
          </subsection>
          <subsection id="id5b9d6623c93f47c7ac7ebba0ea7884b1">
            <enum>(c)</enum>
            <header>Costs</header>
						<paragraph id="id15c78c0fba93408e8639c7e0f6c28f0c">
              <enum>(1)</enum>
              <header>Authorized
				licensure fees of secretary</header>
              <text>If a State does not establish a
				licensing program for a third-party logistics provider, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall
				license the third-party logistics provider located in such State and may
				collect a reasonable fee in such amount necessary to reimburse the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				for costs associated with establishing and administering the licensure program
				and conducting periodic inspections under this section. The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall
				adjust fee rates as needed on an annual basis to generate only the amount of
				revenue needed to perform this service. Fees authorized under this paragraph
				shall be collected and available for obligation only to the extent and in the
				amount provided in advance in appropriations Acts. Such fees are authorized to
				remain available until expended.</text>
						</paragraph>
            <paragraph id="idbf4aba1aa306471590387a742d020722">
              <enum>(2)</enum>
              <header>State licensing
				fees</header>
							<subparagraph id="id9a058ebb69b24812adf2db1c3db474be">
                <enum>(A)</enum>
                <header>State
				established program</header>
                <text>Nothing in this Act shall prohibit a State
				that has established a program to license a third-party logistics provider from
				collecting fees from a third-party logistics provider for such a
				license.</text>
							</subparagraph>
              <subparagraph id="id094123c5b38a4f72a1554b87de9fb7aa">
                <enum>(B)</enum>
                <header>No State
				established program</header>
                <text>A State that does not establish a program to
				license a third-party logistics provider in accordance with this section shall
				be prohibited from collecting a State licensing fee from a third-party
				logistics provider.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection id="idea937351f7284d5596d7e3469b212f9f">
            <enum>(d)</enum>
            <header>License
				regulations</header>
						<paragraph id="id9fc4750319ba4209a907afd2021c2234">
              <enum>(1)</enum>
              <header>In
				general</header>
              <text>Not later than 2 years after the date of enactment of the
				<short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                </short-title>,
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall issue regulations regarding the minimum issuance and
				eligibility requirements for licensing under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584/ss:a" proposed="true">subsection (a)</cato:entity-ref>, including the
				revocation and reissuance of such license, to third-party logistics providers
				under this section.</text>
						</paragraph>
            <paragraph id="idda3b7a60250a4185a59737d102798137">
              <enum>(2)</enum>
              <header>Content</header>
              <text>Such
				regulations shall—</text>
							<subparagraph id="ide4e079607eb244ffac29d0e077934cb3">
                <enum>(A)</enum>
                <text>establish a
				process by which a third-party accreditation program approved by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				shall, upon request by a third-party logistics provider, issue a license to
				each third-party logistics provider that meets the minimum requirements set
				forth in this section;</text>
							</subparagraph>
              <subparagraph id="id6b4087267ce54f518675963f13ff4c4e">
                <enum>(B)</enum>
                <text>establish a
				process by which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall issue a license to each third-party
				logistics provider that meets the minimum requirements set forth in this
				section if the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> is not able to approve a third-party accreditation
				program because no such program meets the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary’s</cato:entity-ref> requirements necessary
				for approval of such a third-party accreditation program;</text>
							</subparagraph>
              <subparagraph id="id7737451aee744d63ac5c96d74d3146b1">
                <enum>(C)</enum>
                <text>require that the
				entity complies with storage practices, as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> for such
				facility, including—</text>
								<clause id="id80c5ea7904bd48178b916932dc47f263">
                  <enum>(i)</enum>
                  <text>maintaining
				access to warehouse space of suitable size to facilitate safe operations,
				including a suitable area to quarantine suspect product;</text>
								</clause>
                <clause id="id5b6c5367752a4049821a7b688c7374a0">
                  <enum>(ii)</enum>
                  <text>maintaining
				adequate security; and</text>
								</clause>
                <clause id="id191427f569954cb9b9789e2afb720775">
                  <enum>(iii)</enum>
                  <text>having written
				policies and procedures to—</text>
									<subclause id="id8b4d0a9e3522471c974c6ca284891ff7">
                    <enum>(I)</enum>
                    <text>address receipt,
				security, storage, inventory, shipment, and distribution of a product;</text>
									</subclause>
                  <subclause id="idc7600bc9717348449a7a5b6b6f907c49">
                    <enum>(II)</enum>
                    <text>identify,
				record, and report confirmed losses or thefts in the United States;</text>
									</subclause>
                  <subclause id="id33eff123ccb54a26a194d24d3b18088e">
                    <enum>(III)</enum>
                    <text>correct errors
				and inaccuracies in inventories;</text>
									</subclause>
                  <subclause id="idb9d716b2ee064d80b849c2c3bf452cb0">
                    <enum>(IV)</enum>
                    <text>provide support
				for manufacturer recalls;</text>
									</subclause>
                  <subclause id="id2a738e8a36704fd3bb3775ae003ba2cb">
                    <enum>(V)</enum>
                    <text>prepare for,
				protect against, and address any reasonably foreseeable crisis that affects
				security or operation at the facility, such as a strike, fire, or flood;</text>
									</subclause>
                  <subclause id="ida5cdf1beee304f1db1fe78ce899e2ab7">
                    <enum>(VI)</enum>
                    <text>ensure that any
				expired product is segregated from other products and returned to the
				manufacturer or re-packager or destroyed;</text>
									</subclause>
                  <subclause id="id2081a0a10c074941851e333a7583c086">
                    <enum>(VII)</enum>
                    <text>maintain the
				capability to electronically trace the receipt and outbound distribution of a
				product, and supplies and records of inventory; and</text>
									</subclause>
                  <subclause id="id0e2b23a6f024474c85b53afce8ae0b26">
                    <enum>(VIII)</enum>
                    <text>quarantine or
				destroy a suspect product if directed to do so by the respective manufacturer,
				wholesale distributor, dispenser or an authorized government agency;</text>
									</subclause>
                </clause>
              </subparagraph>
              <subparagraph id="id34660072ae884fd8aa461d9593bb79a5">
                <enum>(D)</enum>
                <text>provide for
				periodic inspection by the licensing authority, as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>,
				of such facility warehouse space to ensure compliance with this section;</text>
							</subparagraph>
              <subparagraph id="id2471c4af99624b6c825040c56b4bfe14">
                <enum>(E)</enum>
                <text>prohibit a
				facility from having as a manager or designated representative anyone convicted
				of any felony violation of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:i">subsection (i)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:k">(k) of section 301</cato:entity-ref> or any
				violation of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/18/1365">
                    <external-xref legal-doc="usc" parsable-cite="usc/18/1365">section 1365</external-xref> of title 18, United States Code</cato:entity-ref> relating to product
				tampering;</text>
							</subparagraph>
              <subparagraph id="id92e5dae1d6614f7b95bb735e3511ee5e">
                <enum>(F)</enum>
                <text>provide for
				mandatory background checks of a facility manager or a designated
				representative of such manager; and</text>
							</subparagraph>
              <subparagraph id="idad98831e5b08418999aacd836a09b043">
                <enum>(G)</enum>
                <text>require a
				third-party logistics provider to provide the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, upon a request by the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, a list of all product manufacturers, wholesale distributors, and
				dispensers for whom the third-party logistics provider provides services at
				such facility.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id948c143b4a7641cc8886f068e3e33487">
              <enum>(3)</enum>
              <header>Procedure</header>
              <text>In
				promulgating the regulations under this subsection, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall,
				notwithstanding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/5/553">
                  <external-xref legal-doc="usc" parsable-cite="usc/5/553">section 553</external-xref> of title 5, United States Code</cato:entity-ref>—</text>
							<subparagraph id="idc8f083c8c1994ae28b0fadf4954fadcb">
                <enum>(A)</enum>
                <text>issue a notice of
				proposed rulemaking that includes a copy of the proposed regulation;</text>
							</subparagraph>
              <subparagraph id="idb1a56325daff479a92d993f232b94a11">
                <enum>(B)</enum>
                <text>provide a period
				of not less than 60 days for comments on the proposed regulation; and</text>
							</subparagraph>
              <subparagraph id="ideff0f394b52f4b9396c53830167504dd">
                <enum>(C)</enum>
                <text>provide that the
				final regulation takes effect upon the expiration of 1 year after the date that
				such final regulation is issued.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection id="ida5ceff423dc84482803f1ba22ba5c705">
            <enum>(e)</enum>
            <header>Renewal of
				licenses</header>
            <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall develop procedures for license
				renewal. Licenses issued under this section shall expire on the date that is 3
				years after issuance of the license. Such an expired license may be renewed for
				additional 3-year periods according to procedures developed by the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>.</text>
					</subsection>
        </section>
        <section id="idbebc2748d5ba419bbfd308593816b39f">
          <enum>585.</enum>
          <header>Uniform
				national policy</header>
					<subsection id="ida7eba37d583e40ec911f4d96541f5350">
            <enum>(a)</enum>
            <header>Product tracing
				and other requirements</header>
            <text>Beginning on the date of enactment of the
				<short-title>
                <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
              </short-title>,
				no State or political subdivision of a State may establish or continue in
				effect any requirements for tracing drugs through the distribution system
				(including any requirements with respect to statements of distribution history,
				transaction history, transaction information, or transaction statement of a
				pharmaceutical product as such product changes ownership in the supply chain,
				or verification, investigation, disposition, notification, or record-keeping
				relating to such systems, including paper or electronic pedigree systems or for
				tracking and tracing drugs throughout the distribution system) which are
				inconsistent with, more stringent than, or in addition to, any requirements
				applicable under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e" proposed="true">section 503(e)</cato:entity-ref> (as amended by such Act) or this subchapter (or
				regulations issued thereunder), or which are inconsistent with—</text>
						<paragraph id="id45F25DB9E1C7427D9196A4DD131CA19B">
              <enum>(1)</enum>
              <text>any waiver,
				exception, or exemption issued by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:581" proposed="true">section 581</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582" proposed="true">582</cato:entity-ref>;
				or</text>
						</paragraph>
            <paragraph id="idC61D41DB51CC40E196E5BDC57452811C">
              <enum>(2)</enum>
              <text>any restrictions
				specified in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582" proposed="true">section 582</cato:entity-ref>.</text>
						</paragraph>
          </subsection>
          <subsection id="idd2c1fcddf95d471ab8ebed5bf4d3f78f">
            <enum>(b)</enum>
            <header>Distribution
				and licensing standards</header>
						<paragraph id="id896cd02a95694462a77495effa35ad93">
              <enum>(1)</enum>
              <header>In
				general</header>
              <text>Beginning on the date of enactment of the
				<short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                </short-title>,
				no State or political subdivision of a State may establish or continue any
				standards, requirements, or regulations with respect to wholesale drug
				distributor or third-party logistics provider licensure that are less stringent
				than the standards and requirements applicable under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e" proposed="true">section 503(e)</cato:entity-ref> (as amended
				by such Act), in the case of a wholesale distributor, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584" proposed="true">section 584</cato:entity-ref>, in the
				case of a third-party logistics provider.</text>
						</paragraph>
            <paragraph commented="no" id="id2C49451AD5274DF197052D8CCE43ED98">
              <enum>(2)</enum>
              <header>State
				regulation of third-party logistics providers</header>
              <text>No State shall
				regulate third-party logistics providers as wholesale distributors.</text>
						</paragraph>
            <paragraph id="id506663cdf8e14cb984761638501952ca">
              <enum>(3)</enum>
              <header>Administration
				fees</header>
              <text>Notwithstanding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:585/ss:b/p:1" proposed="true">paragraph (1)</cato:entity-ref>, a State may administer fee
				collections for effectuating the wholesale drug distributor and third-party
				logistics provider licensure requirements under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e" proposed="true">sections 503(e)</cato:entity-ref> (as amended by
				the <short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security
				Act</cato:entity-ref>
                </short-title>), <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:583" proposed="true">583</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584" proposed="true">584</cato:entity-ref>.</text>
						</paragraph>
            <paragraph id="id2c56eca5d6784da49ae540dced9526c3">
              <enum>(4)</enum>
              <header>Enforcement,
				suspension, and revocation of licenses</header>
              <text>Notwithstanding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:585/ss:b/p:1" proposed="true">paragraph
				(1)</cato:entity-ref>, a State—</text>
							<subparagraph id="id578cdff0f637470dae33e88394979a58">
                <enum>(A)</enum>
                <text>may take
				administrative action, including fines, to enforce a licensure requirement
				promulgated by the State in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e" proposed="true">section 503(e)</cato:entity-ref> (as amended by the
				<short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
                  </short-title>)
				or this subchapter;</text>
							</subparagraph>
              <subparagraph id="idc80c97fed838400086bff0c36330e877">
                <enum>(B)</enum>
                <text>may provide for
				the suspension or revocation of licenses issued by the State for violations of
				the laws of such State;</text>
							</subparagraph>
              <subparagraph id="id46b41927d3d84d47800d0f20d50b54be">
                <enum>(C)</enum>
                <text>upon conviction
				of violations of Federal, State, or local drug laws or regulations, may provide
				for fines, imprisonment, or civil penalties; and</text>
							</subparagraph>
              <subparagraph id="id1dde9b9e10fd4849967e8c40c4765d89">
                <enum>(D)</enum>
                <text>may regulate
				activities of licensed entities in a manner that is consistent with product
				tracing requirements under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582" proposed="true">section 582</cato:entity-ref>.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection commented="no" display-inline="no-display-inline" id="id7613345DB5774D72A366B935E4C4861E">
            <enum>(c)</enum>
            <header>Exception</header>
            <text>Nothing
				in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:585/ss:a" proposed="true">subsection (a)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:585/ss:b" proposed="true">(b)</cato:entity-ref> shall be construed to preempt State requirements
				related to the distribution of prescription drugs if such requirements are not
				related to product tracing as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:585/ss:a" proposed="true">subsection (a)</cato:entity-ref>, including any
				requirements applicable under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e" proposed="true">section 503(e)</cato:entity-ref> (as amended by the
				<short-title>
                <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act" proposed="true">Drug Supply Chain Security Act</cato:entity-ref>
              </short-title>)
				or this subchapter (or regulations issued
				thereunder).</text>
					</subsection>
        </section>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
		</section>
    <section id="idbc50988f765742969ebc9251bee48e0c">
      <enum>6.</enum>
      <header>Penalties</header>
			<subsection id="id50b00bdd84524b7db102dbda65bbd094">
        <enum>(a)</enum>
        <header>Prohibited
			 act</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:t">Section 301(t) of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref>
			 (<external-xref legal-doc="usc" parsable-cite="usc/21/331">
              <cato:entity-ref entity-type="uscode" value="usc/21/331/t">21 U.S.C. 331(t)</cato:entity-ref>
            </external-xref>)</cato:entity>, is amended—</text>
				<paragraph id="id1a5b7cf278f24a7ba87f612855123962">
          <enum>(1)</enum>
          <text>by striking
			 <quote>or</quote> after <quote>the requirements of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:d">section 503(d)</cato:entity-ref>,</quote>;
			 and</text>
				</paragraph>
        <paragraph id="idf3dbe1b54b024640b82fe19de9d29fdf">
          <enum>(2)</enum>
          <text>by inserting
			 <quote>, failure to comply with the requirements under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582" proposed="true">section 582</cato:entity-ref>, the failure
			 to comply with the requirements under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:584" proposed="true">section 584</cato:entity-ref>, as applicable,</quote> after
			 <quote>in violation of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e" proposed="true">section 503(e)</cato:entity-ref>
            </quote>.</text>
				</paragraph>
      </subsection>
      <subsection id="idb7e8574f4aee4968aaf4c485d4664878">
        <enum>(b)</enum>
        <header>Misbranding</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:502">Section
			 502 of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/352">
              <cato:entity-ref entity-type="uscode" value="usc/21/352">21 U.S.C. 352</cato:entity-ref>
            </external-xref>)</cato:entity>, is amended by
			 adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="id8be843ad3a314d658098b00b879d1f25" style="OLC">
					<subsection id="id4da15c7bfbf341c98ba1645b626804c2">
            <enum>(bb)</enum>
            <text>If it is a drug
				and it fails to bear the product identifier as required by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:582" proposed="true">section
				582</cato:entity-ref>.</text>
					</subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
    </section>
    <section id="id919BAF362748462F8C1AB792EDD7E534">
      <enum>7.</enum>
      <header>Conforming
			 amendments</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:303/ss:b/p:1/sp:D">Section
			 303(b)(1)(D) of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/333/b/1/D">21 U.S.C.
			 333(b)(1)(D)</cato:entity-ref>)</cato:entity> is amended by striking <quote>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:2/sp:A">503(e)(2)(A)</cato:entity-ref>
        </quote> and inserting
			 <quote>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1" proposed="true">503(e)(1)</cato:entity-ref>
        </quote>.</text>
		</section>
    <section id="id5374815F273F423C980ED14B747BC243">
      <enum>8.</enum>
      <header>Savings
			 clause</header>
      <text display-inline="no-display-inline">Except as provided in
			 the amendments made by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act/s:4/ss:a/p:1" proposed="true">paragraphs (1)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act/s:4/ss:a/p:2" proposed="true">(2)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act/s:4/ss:a/p:3" proposed="true">(3) of section 4(a)</cato:entity-ref> and by
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Drug Supply Chain Security Act/s:6/ss:a" proposed="true">section 6(a)</cato:entity-ref>, nothing in this Act (including the amendments made by this Act)
			 shall be construed as altering any authority of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and
			 Human Services</cato:entity-ref> with respect to a drug subject to <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1">section 503(b)(1) of the
			 Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/353">
            <cato:entity-ref entity-type="uscode" value="usc/21/353/b/1">21 U.S.C. 353(b)(1)</cato:entity-ref>
          </external-xref>)</cato:entity> under any other
			 provision of such Act or the <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Public Health Service Act">Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/201/etseq">42 U.S.C. 201 et
			 seq.</cato:entity-ref>)</cato:entity>.</text>
		</section>
  </legis-body>
</bill>
</doc>